Sandbox coretopics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Blanked the page)
No edit summary
 
Line 1: Line 1:
__NOTOC__


{| class="wikitable"
! Specialty
! Topic
! Section
! Figure
! Table
|-
| Cardiology||[[Electrocardiography]]||Approach||QRS axis||–
|-
| Cardiology||[[Electrocardiography]]||Left axis deviation (LAD)||–||–
|-
| Cardiology||[[Electrocardiography]]||Right axis deviation (RAD)||–||Bunble branch blocks
|-
| Cardiology||[[Electrocardiography]]||Prolonged QT interval||ECG P Wave Criteria||–
|-
| Cardiology||[[Electrocardiography]]||Left ventricular hypertrophy (LVH)||–||–
|-
| Cardiology||[[Electrocardiography]]||Right ventricular hypertrophy (RVH)||–||–
|-
| Cardiology||[[Electrocardiography]]||Ddx of dominant R wave in V1 or V2||–||–
|-
| Cardiology||[[Electrocardiography]]||Poor R wave progression (PRWP)||–||–
|-
| Cardiology||[[Electrocardiography]]||Pathologic Q waves||–||–
|-
| Cardiology||[[Electrocardiography]]||ST elevation (STE)||–||–
|-
| Cardiology||[[Electrocardiography]]||ST depression (STD)||–||–
|-
| Cardiology||[[Electrocardiography]]||T wave inversion (TWI)||–||–
|-
| Cardiology||[[Electrocardiography]]||Low voltage||–||–
|-
| Cardiology||[[Chest pain]]||Causes of Chest Pain||–||Causes of Chest Pain
|-
| Cardiology||[[Chest pain]]||Initial approach||–||–
|-
| Cardiology||[[Noninvasive evaluation of cad]]||Noninvasive Evaluation of CAD||–||Noninvasive Evaluation of CAD
|-
| Cardiology||[[Noninvasive evaluation of cad]]||Stress testing||–||–
|-
| Cardiology||[[Noninvasive evaluation of cad]]||Test results||–||–
|-
| Cardiology||[[Noninvasive evaluation of cad]]||High-risk test results||–||–
|-
| Cardiology||[[Noninvasive evaluation of cad]]||Myocardial viability||–||–
|-
| Cardiology||[[Noninvasive evaluation of cad]]||CT & MR coronary angio||–||–
|-
| Cardiology||[[Noninvasive evaluation of cad]]||Coronary artery calcium score||–||–
|-
| Cardiology||[[Coronary angiography and revascularization]]||Indications for coronary angiography in stable CAD or asx Pts||–||–
|-
| Cardiology||[[Coronary angiography and revascularization]]||Precath checklist||–||–
|-
| Cardiology||[[Coronary angiography and revascularization]]||Coronary revascularization in stable CAD||–||–
|-
| Cardiology||[[Coronary angiography and revascularization]]||PCI||–||–
|-
| Cardiology||[[Coronary angiography and revascularization]]||Post-PCI complications||–||–
|-
| Cardiology||[[Acute coronary syndromes]]||Ddx (causes of myocardial ischemia/infarction other than atherosclerotic plaque rupture)||–||Spectrum of Acute Coronary Syndromes
|-
| Cardiology||[[Acute coronary syndromes]]||Clinical manifestations||–||–
|-
| Cardiology||[[Acute coronary syndromes]]||Physical exam||–||–
|-
| Cardiology||[[Acute coronary syndromes]]||Diagnostic studies||–||Localization of MI
|-
| Cardiology||[[Acute coronary syndromes]]||Prinzmetal’s (variant) angina||–||–
|-
| Cardiology||[[Acute coronary syndromes]]||Approach to triage||–||Likelihood of ACS
|-
| Cardiology||[[Acute coronary syndromes]]||Coronary angiography||–||–
|-
| Cardiology||[[Ua/nstemi]]||Approach to UA/NSTEMI||Approach to UA/NSTEMI||–
|-
| Cardiology||[[Ua/nstemi]]||TIMI Risk Score for UA/NSTEMI||–||TIMI Risk Score for UA/NSTEMI
|-
| Cardiology||[[Ua/nstemi]]||Anti-Ischemic and Antiplatelet Therapy for UA/NSTEMI||–||Anti-Ischemic and Antiplatelet Therapy for UA/NSTEMI
|-
| Cardiology||[[Ua/nstemi]]||Anticoagulant Therapy for UA/NSTEMI||–||Anticoagulant Therapy for UA/NSTEMI
|-
| Cardiology||[[Stemi]]||Requisite STE (at J point)||–||–
|-
| Cardiology||[[Stemi]]||Reperfusion (“time is muscle”)||–||Fibrinolysis vs Hospital Transfer for Primary PCI
|-
| Cardiology||[[Stemi]]||Primary PCI||–||–
|-
| Cardiology||[[Stemi]]||Fibrinolysis||–||Contraindications to Fibrinolysis
|-
| Cardiology||[[Stemi]]||Non-primary PCI||–||–
|-
| Cardiology||[[Stemi]]||Antiplatelet Therapy for STEMI||–||Antiplatelet Therapy for STEMI
|-
| Cardiology||[[Stemi]]||Anticoagulant Therapy for STEMI||–||Anticoagulant Therapy for STEMI
|-
| Cardiology||[[Stemi]]||Immediate Adjunctive Therapy for STEMI||–||Immediate Adjunctive Therapy for STEMI
|-
| Cardiology||[[Stemi]]||LV failure||–||–
|-
| Cardiology||[[Stemi]]||Inferior MI complications||–||–
|-
| Cardiology||[[Stemi]]||Mechanical complications||–||–
|-
| Cardiology||[[Stemi]]||Post-MI Arrhythmias||–||Other Post-MI Complications
|-
| Cardiology||[[Stemi]]||Prognosis based on Killip Class||–||Prognosis based on Killip Class
|-
| Cardiology||[[Stemi]]||Prognosis based on Forrester Class||–||Prognosis based on Forrester Class
|-
| Cardiology||[[Pre-discharge checklist and long-term post-acs management]]||Risk stratification||–||–
|-
| Cardiology||[[Pre-discharge checklist and long-term post-acs management]]||Medications (barring contraindications)||–||–
|-
| Cardiology||[[Pre-discharge checklist and long-term post-acs management]]||ICD||–||–
|-
| Cardiology||[[Pre-discharge checklist and long-term post-acs management]]||Risk factors and lifestyle modifications||–||–
|-
| Cardiology||[[Pa catheter and tailored therapy]]||Rationale||PA Catheter Waveforms||–
|-
| Cardiology||[[Pa catheter and tailored therapy]]||Indications||–||–
|-
| Cardiology||[[Pa catheter and tailored therapy]]||Efficacy concerns||–||–
|-
| Cardiology||[[Pa catheter and tailored therapy]]||Placement||–||–
|-
| Cardiology||[[Pa catheter and tailored therapy]]||Complications||–||–
|-
| Cardiology||[[Pa catheter and tailored therapy]]||Intracardiac pressures||–||–
|-
| Cardiology||[[Pa catheter and tailored therapy]]||Cardiac output||–||–
|-
| Cardiology||[[Pa catheter and tailored therapy]]||Tailored therapy in cardiogenic shock||–||Hemodynamic Profiles of Various Forms of Shock
|-
| Cardiology||[[Heart failure]]||Definitions||–||–
|-
| Cardiology||[[Heart failure]]||History||–||–
|-
| Cardiology||[[Heart failure]]||Functional classification (New York Heart Association class)||–||–
|-
| Cardiology||[[Heart failure]]||Physical exam (“2-minute” hemodynamic profile)||–||–
|-
| Cardiology||[[Heart failure]]||Evaluation for the presence of heart failure||–||–
|-
| Cardiology||[[Heart failure]]||Evaluation of the causes of heart failure||Approach to left-sided heart failure||–
|-
| Cardiology||[[Heart failure]]||Precipitants of acute heart failure||–||–
|-
| Cardiology||[[Heart failure]]||Treatment of acute decompensated heart failure||–||Treatment of acute decompensated heart failure
|-
| Cardiology||[[Heart failure]]||Treatment of advanced heart failure||–||Recommended Chronic Therapy by HF Stage
|-
| Cardiology||[[Heart failure]]||Heart failure with reduced EF (HFrEF)||–||Treatment of HFrEF
|-
| Cardiology||[[Heart failure]]||Heart failure with preserved EF (HFpEF)||–||–
|-
| Cardiology||[[Dilated cardiomyopathy]]||Definition and epidemiology||–||–
|-
| Cardiology||[[Dilated cardiomyopathy]]||Etiologies||–||–
|-
| Cardiology||[[Dilated cardiomyopathy]]||Clinical manifestations||–||–
|-
| Cardiology||[[Dilated cardiomyopathy]]||Diagnostic studies and workup||–||–
|-
| Cardiology||[[Dilated cardiomyopathy]]||Treatment||–||–
|-
| Cardiology||[[Hypertrophic cardiomyopathy]]||Definition and epidemiology||–||–
|-
| Cardiology||[[Hypertrophic cardiomyopathy]]||Pathology||–||–
|-
| Cardiology||[[Hypertrophic cardiomyopathy]]||Pathophysiology||–||–
|-
| Cardiology||[[Hypertrophic cardiomyopathy]]||Clinical manifestations||–||–
|-
| Cardiology||[[Hypertrophic cardiomyopathy]]||Physical exam||–||–
|-
| Cardiology||[[Hypertrophic cardiomyopathy]]||Diagnostic studies||–||–
|-
| Cardiology||[[Hypertrophic cardiomyopathy]]||Treatment||–||–
|-
| Cardiology||[[Restrictive cardiomyopathy]]||Definition||–||–
|-
| Cardiology||[[Restrictive cardiomyopathy]]||Etiology||–||–
|-
| Cardiology||[[Restrictive cardiomyopathy]]||Pathology & pathophysiology||–||–
|-
| Cardiology||[[Restrictive cardiomyopathy]]||Clinical manifestations||–||–
|-
| Cardiology||[[Restrictive cardiomyopathy]]||Physical exam||–||–
|-
| Cardiology||[[Restrictive cardiomyopathy]]||Diagnostic studies||–||–
|-
| Cardiology||[[Restrictive cardiomyopathy]]||Treatment||–||–
|-
| Cardiology||[[Aortic stenosis]]||Etiology||–||–
|-
| Cardiology||[[Aortic stenosis]]||Clinical manifestations||–||–
|-
| Cardiology||[[Aortic stenosis]]||Physical exam||Hemodynamics of Aortic Stenosis||–
|-
| Cardiology||[[Aortic stenosis]]||Diagnostic studies||–||Classification of Aortic Stenosis
|-
| Cardiology||[[Aortic stenosis]]||Treatment||–||–
|-
| Cardiology||[[Aortic insufficiency]]||Etiology||–||–
|-
| Cardiology||[[Aortic insufficiency]]||Clinical manifestations||–||Classic Eponymous Signs in Chronic Aortic Insufficiency
|-
| Cardiology||[[Aortic insufficiency]]||Physical exam||Hemodynamics of Aortic Insufficiency||–
|-
| Cardiology||[[Aortic insufficiency]]||Diagnostic studies||–||–
|-
| Cardiology||[[Aortic insufficiency]]||Treatment||–||–
|-
| Cardiology||[[Mitral regurgitation]]||Etiology||–||–
|-
| Cardiology||[[Mitral regurgitation]]||Clinical manifestations||–||–
|-
| Cardiology||[[Mitral regurgitation]]||Physical exam||Hemodynamics of Mitral Regurgitation||–
|-
| Cardiology||[[Mitral regurgitation]]||Diagnostic studies||–||Classification of Mitral Regurgitation
|-
| Cardiology||[[Mitral regurgitation]]||Treatment||–||–
|-
| Cardiology||[[Mitral stenosis]]||Etiology||–||–
|-
| Cardiology||[[Mitral stenosis]]||Clinical manifestations||–||–
|-
| Cardiology||[[Mitral stenosis]]||Physical exam||Hemodynamics of Mitral Stenosis||–
|-
| Cardiology||[[Mitral stenosis]]||Diagnostic studies||–||Classification of Mitral Stenosis
|-
| Cardiology||[[Mitral stenosis]]||Treatment||–||–
|-
| Cardiology||[[Mitral valve prolapse]]||Definition and etiology||–||–
|-
| Cardiology||[[Mitral valve prolapse]]||Clinical manifestations||–||–
|-
| Cardiology||[[Mitral valve prolapse]]||Physical exam||–||–
|-
| Cardiology||[[Mitral valve prolapse]]||Treatment||–||–
|-
| Cardiology||[[Tricuspid regurgitation]]||Tricuspid regurgitation||–||–
|-
| Cardiology||[[Prosthetic heart valves]]||Mechanical||Superior View of Heart Valves||–
|-
| Cardiology||[[Prosthetic heart valves]]||Bioprosthetic||–||–
|-
| Cardiology||[[Prosthetic heart valves]]||Physical exam||–||–
|-
| Cardiology||[[Prosthetic heart valves]]||Anticoagulation & antiplatelet therapy||–||Periprocedural Bridging of Anticoagulation in Pts with MV
|-
| Cardiology||[[Prosthetic heart valves]]||Correction of overanticoagulation||–||–
|-
| Cardiology||[[Prosthetic heart valves]]||Endocarditis prophylaxis||–||–
|-
| Cardiology||[[Prosthetic heart valves]]||Complications||–||–
|-
| Cardiology||[[Pericardial disease]]||Anatomy||–||–
|-
| Cardiology||[[Pericardial disease]]||Disease states||–||–
|-
| Cardiology||[[Pericarditis and pericardial effusion]]||Etiology||–||Etiologies of Acute Pericarditis
|-
| Cardiology||[[Pericarditis and pericardial effusion]]||Clinical manifestations||–||–
|-
| Cardiology||[[Pericarditis and pericardial effusion]]||Physical exam||–||–
|-
| Cardiology||[[Pericarditis and pericardial effusion]]||Diagnostic studies||–||–
|-
| Cardiology||[[Pericarditis and pericardial effusion]]||Workup for effusion||–||–
|-
| Cardiology||[[Pericarditis and pericardial effusion]]||Treatment of pericarditis||–||–
|-
| Cardiology||[[Pericardial tamponade]]||Etiology||–||–
|-
| Cardiology||[[Pericardial tamponade]]||Pathophysiology||–||–
|-
| Cardiology||[[Pericardial tamponade]]||Clinical manifestations||–||–
|-
| Cardiology||[[Pericardial tamponade]]||Physical exam||–||–
|-
| Cardiology||[[Pericardial tamponade]]||Diagnostic studies||–||–
|-
| Cardiology||[[Pericardial tamponade]]||Treatment||–||–
|-
| Cardiology||[[Constrictive pericarditis]]||Etiology||–||Constrictive Pericarditis vs Restrictive Cardiomyopathy
|-
| Cardiology||[[Constrictive pericarditis]]||Pathophysiology||–||–
|-
| Cardiology||[[Constrictive pericarditis]]||Clinical manifestations||–||–
|-
| Cardiology||[[Constrictive pericarditis]]||Physical exam||–||–
|-
| Cardiology||[[Constrictive pericarditis]]||Diagnostic studies||–||–
|-
| Cardiology||[[Constrictive pericarditis]]||Treatment||–||–
|-
| Cardiology||[[Hypertension]]||Classification||–||JNC VII Classification of Hypertension
|-
| Cardiology||[[Hypertension]]||Epidemiology||–||–
|-
| Cardiology||[[Hypertension]]||Etiologies||–||Secondary Causes of Hypertension
|-
| Cardiology||[[Hypertension]]||Standard workup||–||–
|-
| Cardiology||[[Hypertension]]||Complications of HTN||–||–
|-
| Cardiology||[[Hypertension]]||Treatment||–||–
|-
| Cardiology||[[Hypertensive crises]]||Definitions||–||–
|-
| Cardiology||[[Hypertensive crises]]||Precipitants||–||–
|-
| Cardiology||[[Hypertensive crises]]||Treatment||–||Drugs for Hypertensive Crises
|-
| Cardiology||[[Aortic aneurysms]]||Definitions||–||–
|-
| Cardiology||[[Aortic aneurysms]]||Epidemiology||–||–
|-
| Cardiology||[[Aortic aneurysms]]||Pathophysiology||–||–
|-
| Cardiology||[[Aortic aneurysms]]||Screening||–||–
|-
| Cardiology||[[Aortic aneurysms]]||Diagnostic studies||–||–
|-
| Cardiology||[[Aortic aneurysms]]||Treatment||–||–
|-
| Cardiology||[[Acute aortic syndromes]]||Definitions||–||–
|-
| Cardiology||[[Acute aortic syndromes]]||Classification||–||–
|-
| Cardiology||[[Acute aortic syndromes]]||Risk factors||–||–
|-
| Cardiology||[[Acute aortic syndromes]]||Clinical manifestations||–||Clinical Manifestations and Physical Exam of Acute Aortic Syndromes
|-
| Cardiology||[[Acute aortic syndromes]]||Diagnostic studies||–||–
|-
| Cardiology||[[Acute aortic syndromes]]||Treatment||–||–
|-
| Cardiology||[[Acute aortic syndromes]]||Complications||–||–
|-
| Cardiology||[[Bradycardias, av block, and av dissociation]]||Sinus bradycardia (SB) ||–||–
|-
| Cardiology||[[Bradycardias, av block, and av dissociation]]||Sick sinus syndrome (SSS)||–||–
|-
| Cardiology||[[Bradycardias, av block, and av dissociation]]||AV Block||–||Classification of AV Block
|-
| Cardiology||[[Bradycardias, av block, and av dissociation]]||AV Dissociation||–||–
|-
| Cardiology||[[Bradycardias, av block, and av dissociation]]||Temporary pacing wires||–||–
|-
| Cardiology||[[Supraventricular tachycardias]]||Approach||–||Approach to SVT
|-
| Cardiology||[[Supraventricular tachycardias]]||Etiology||–||Common Etiologies of SVT
|-
| Cardiology||[[Supraventricular tachycardias]]||Diagnosis||–||Diagnosis of SVT
|-
| Cardiology||[[Supraventricular tachycardias]]||Treatment||–||Treatment of SVT
|-
| Cardiology||[[Accessory pathways (wolff-parkinson-white)]]||Definitions||Delta wave of WPW Syndrome||–
|-
| Cardiology||[[Accessory pathways (wolff-parkinson-white)]]||Classic tachycardias of WPW||–||–
|-
| Cardiology||[[Accessory pathways (wolff-parkinson-white)]]||Treatment||–||–
|-
| Cardiology||[[Wide-complex tachycardias]]||Etiology||–||–
|-
| Cardiology||[[Wide-complex tachycardias]]||Monomorphic ventricular tachycardia (MMVT)||Epsilon wave in ARVD||–
|-
| Cardiology||[[Wide-complex tachycardias]]||Polymorphic ventricular tachycardia (PMVT)||ECG of Brugada Syndrome||–
|-
| Cardiology||[[Wide-complex tachycardias]]||Diagnostic clues that favor VT (assume until proven o/w)||–||–
|-
| Cardiology||[[Wide-complex tachycardias]]||Long-term management||–||–
|-
| Cardiology||[[Atrial fibrillation]]||Classification||–||–
|-
| Cardiology||[[Atrial fibrillation]]||Epidemiology and etiologies||–||–
|-
| Cardiology||[[Atrial fibrillation]]||Evaluation||–||Approach to Acute AF
|-
| Cardiology||[[Atrial fibrillation]]||Strategies for recurrent AF||–||Rate Control for AF
|-
| Cardiology||[[Atrial fibrillation]]||Cardioversion||–||Antiarrhythmic Drugs for AF
|-
| Cardiology||[[Atrial fibrillation]]||Nonpharmacologic therapy||–||–
|-
| Cardiology||[[Atrial fibrillation]]||Oral anticoagulation||–||Novel Oral Anticoagulants for Nonvalvular AF
|-
| Cardiology||[[Syncope]]||Definition||–||–
|-
| Cardiology||[[Syncope]]||Etiologies||–||–
|-
| Cardiology||[[Syncope]]||Workup||Approach to Syncope||–
|-
| Cardiology||[[Syncope]]||Other diagnostic studies||–||–
|-
| Cardiology||[[Syncope]]||High-risk features||–||–
|-
| Cardiology||[[Syncope]]||Treatment||–||–
|-
| Cardiology||[[Syncope]]||Prognosis||–||–
|-
| Cardiology||[[Intracardiac devices]]||Pacemaker Code||–||Pacemaker Code
|-
| Cardiology||[[Intracardiac devices]]||Common Pacing Modes||–||Common Pacing Modes
|-
| Cardiology||[[Intracardiac devices]]||Indications for Permanent Pacing||–||Indications for Permanent Pacing
|-
| Cardiology||[[Intracardiac devices]]||Permanent Pacemaker Complications||–||Permanent Pacemaker Complications
|-
| Cardiology||[[Intracardiac devices]]||Cardiac resynch therapy (CRT)/Biventricular (BiV) pacing||–||–
|-
| Cardiology||[[Intracardiac devices]]||Implantable cardiac defibrillator (ICD)||–||–
|-
| Cardiology||[[Intracardiac devices]]||Device infection||–||–
|-
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Clinical Assessment||–||Clinical Assessment
|-
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Surgery-Specific Risk||–||Surgery-Specific Risk
|-
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Functional Capacity||–||Functional Capacity
|-
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Noninvasive Testing Result||–||Noninvasive Testing Result
|-
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Preoperative evaluation||ACC/AHA approach to preoperative cardiovascular evaluation for noncardiac surgery||–
|-
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Preoperative testing and assessment||–||–
|-
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Pre- & perioperative management||–||–
|-
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Perioperative β-blocker||–||–
|-
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Postoperative monitoring||–||–
|-
| Cardiology||[[Peripheral artery disease]]||Clinical features||–||–
|-
| Cardiology||[[Peripheral artery disease]]||Diagnosis||–||–
|-
| Cardiology||[[Peripheral artery disease]]||Treatment||–||–
|-
| Cardiology||[[Peripheral artery disease]]||Acute limb ischemia (ALI)||–||–
|-
| Pulmonary||[[Dyspnea]]||Etiologies||–||Etiologies of Dyspnea
|-
| Pulmonary||[[Dyspnea]]||Evaluation||–||–
|-
| Pulmonary||[[Pulmonary function tests]]||Approach to abnormal PFTs||Approach to abnormal PFTs||–
|-
| Pulmonary||[[Asthma]]||Definition and epidemiology||–||–
|-
| Pulmonary||[[Asthma]]||Clinical manifestations||–||–
|-
| Pulmonary||[[Asthma]]||Physical examination||–||–
|-
| Pulmonary||[[Asthma]]||Diagnostic studies||–||–
|-
| Pulmonary||[[Asthma]]||Ddx||–||–
|-
| Pulmonary||[[Asthma]]||“Asthma plus” syndromes||–||–
|-
| Pulmonary||[[Asthma]]||“Reliever” medications||–||–
|-
| Pulmonary||[[Asthma]]||“Controller” meds||–||–
|-
| Pulmonary||[[Asthma]]||Other||–||–
|-
| Pulmonary||[[Asthma]]||Principles of treatment||–||Asthma Stepwise Therapy
|-
| Pulmonary||[[Asthma exacerbation resident survival guide|Asthma exacerbation]]||Evaluation||–||Severity of Asthma Exacerbation
|-
| Pulmonary||[[Asthma exacerbation resident survival guide|Asthma exacerbation]]||Initial treatment ||Disposition of patients after initial treatment of asthma exacerbation||–
|-
| Pulmonary||[[Asthma exacerbation resident survival guide|Asthma exacerbation]]||ICU-level care||–||–
|-
| Pulmonary||[[Anaphylaxis]]||Definition and pathophysiology||–||–
|-
| Pulmonary||[[Anaphylaxis]]||Diagnosis||–||–
|-
| Pulmonary||[[Anaphylaxis]]||Treatment||–||–
|-
| Pulmonary||[[Anaphylaxis]]||Disposition||–||–
|-
| Pulmonary||[[Chronic obstructive pulmonary disease]]||Definition and epidemiology||–||Emphysema vs Chronic Bronchitis
|-
| Pulmonary||[[Chronic obstructive pulmonary disease]]||Pathogenesis||–||–
|-
| Pulmonary||[[Chronic obstructive pulmonary disease]]||Clinical manifestations||–||–
|-
| Pulmonary||[[Chronic obstructive pulmonary disease]]||Diagnostic studies||–||–
|-
| Pulmonary||[[Chronic obstructive pulmonary disease]]||Chronic treatment||–||–
|-
| Pulmonary||[[Chronic obstructive pulmonary disease]]||Staging and prognosis||–||COPD Staging and Recommended Therapies by GOLD Criteria
|-
| Pulmonary||[[Chronic obstructive pulmonary disease]]||Exacerbation||–||COPD Exacerbation Treatment
|-
| Pulmonary||[[Hemoptysis]]||Definition and pathophysiology||–||–
|-
| Pulmonary||[[Hemoptysis]]||Etiologies||–||Etiologies of Hemoptysis
|-
| Pulmonary||[[Hemoptysis]]||Diagnostic workup||–||–
|-
| Pulmonary||[[Hemoptysis]]||Treatment||–||–
|-
| Pulmonary||[[Bronchiectasis]]||Definition and epidemiology||–||–
|-
| Pulmonary||[[Bronchiectasis]]||Initial workup||–||Etiologies of Bronchiectasis
|-
| Pulmonary||[[Bronchiectasis]]||Treatment||–||–
|-
| Pulmonary||[[Solitary pulmonary nodule]]||Principles||–||Etiologies of SPN
|-
| Pulmonary||[[Solitary pulmonary nodule]]||Initial evaluation||–||–
|-
| Pulmonary||[[Solitary pulmonary nodule]]||Diagnostic studies||–||–
|-
| Pulmonary||[[Solitary pulmonary nodule]]||Management||–||–
|-
| Pulmonary||[[Obstructive sleep apnea]]||Definition and pathophysiology||–||–
|-
| Pulmonary||[[Obstructive sleep apnea]]||Clinical manifestations||–||–
|-
| Pulmonary||[[Obstructive sleep apnea]]||Diagnosis and treatment||–||–
|-
| Pulmonary||[[Interstitial lung disease]]||Workup of ILD||–||–
|-
| Pulmonary||[[Interstitial lung disease]]||Etiologies of ILD||–||Clinical Manifestations of Sarcoidosis
|-
| Pulmonary||[[Interstitial lung disease]]||Idiopathic Interstitial Pneumonias||–||Classification of Idiopathic Interstitial Pneumonia
|-
| Pulmonary||[[Pleural effusion]]||Pathophysiology||–||–
|-
| Pulmonary||[[Pleural effusion]]||Transudates||–||–
|-
| Pulmonary||[[Pleural effusion]]||Exudates||–||–
|-
| Pulmonary||[[Pleural effusion]]||Diagnostic studies||–||Characteristics of Pleural Fluid
|-
| Pulmonary||[[Pleural effusion]]||Treatment||–||–
|-
| Pulmonary||[[Venous thromboembolism]]||Definitions||–||–
|-
| Pulmonary||[[Venous thromboembolism]]||Risk factors||–||Thromboprophylaxis
|-
| Pulmonary||[[Venous thromboembolism]]||Clinical manifestations—DVT||–||Simplified Wells Pretest Probability Scoring for DVT
|-
| Pulmonary||[[Venous thromboembolism]]||Diagnostic studies—DVT||Approach to Suspected DVT||–
|-
| Pulmonary||[[Venous thromboembolism]]||Clinical manifestations—PE||–||Simplified Wells Pretest Probability Scoring for PE
|-
| Pulmonary||[[Venous thromboembolism]]||Diagnostic studies—PE ||Approach to Suspected PE using CTA||–
|-
| Pulmonary||[[Venous thromboembolism]]||Workup for idiopathic VTE||–||–
|-
| Pulmonary||[[Venous thromboembolism]]||Risk stratification for Pts with PE||–||–
|-
| Pulmonary||[[Venous thromboembolism]]||Treatment of VTE||–||–
|-
| Pulmonary||[[Venous thromboembolism]]||Complications & prognosis||–||–
|-
| Pulmonary||[[Pulmonary hypertension]]||Pathobiology||–||Etiologies of Pulmonary Hypertension
|-
| Pulmonary||[[Pulmonary hypertension]]||Clinical manifestations||–||–
|-
| Pulmonary||[[Pulmonary hypertension]]||Physical exam||–||–
|-
| Pulmonary||[[Pulmonary hypertension]]||Diagnostic studies & workup||–||–
|-
| Pulmonary||[[Pulmonary hypertension]]||Treatment||Treatment of PAH||–
|-
| Pulmonary||[[Pulmonary hypertension]]||Treatment||–||Vasoactive Agents for PAH
|-
| Pulmonary||[[Pulmonary hypertension]]||Management of ICU patient||–||–
|-
| Pulmonary||[[Pulmonary hypertension]]||Prognosis||–||–
|-
| Pulmonary||[[Respiratory failure]]||Hypoxia||Workup of acute hypoxemia||–
|-
| Pulmonary||[[Respiratory failure]]||Chemical Causes of Cellular Hypoxia||–||Chemical Causes of Cellular Hypoxia
|-
| Pulmonary||[[Respiratory failure]]||Hypercapnia||–||Etiologies of Hypercapnia
|-
| Pulmonary||[[Mechanical ventilation]]||Indications||–||–
|-
| Pulmonary||[[Mechanical ventilation]]||Choosing settings||–||–
|-
| Pulmonary||[[Mechanical ventilation]]||Pick Ventilator Mode||–||Pick Ventilator Mode
|-
| Pulmonary||[[Mechanical ventilation]]||Choose Volume Targeted or Pressure Targeted||–||Choose Volume Targeted or Pressure Targeted
|-
| Pulmonary||[[Mechanical ventilation]]||Set Remaining Variables||–||Set Remaining Variables
|-
| Pulmonary||[[Mechanical ventilation]]||Initial Settings||–||Initial Settings
|-
| Pulmonary||[[Mechanical ventilation]]||Noninvasive CPAP/Ventilation||–||Noninvasive CPAP/Ventilation
|-
| Pulmonary||[[Mechanical ventilation]]||Tailoring the ventilator settings||–||–
|-
| Pulmonary||[[Mechanical ventilation]]||Acute ventilatory deterioration||Approach to acute ventilatory deterioration||–
|-
| Pulmonary||[[Mechanical ventilation]]||Weaning from the ventilator||–||–
|-
| Pulmonary||[[Mechanical ventilation]]||Complications||–||–
|-
| Pulmonary||[[Acute respiratory distress syndrome]]||New “Berlin” definition||–||–
|-
| Pulmonary||[[Acute respiratory distress syndrome]]||Pathophysiology||–||Etiologies of ARDS
|-
| Pulmonary||[[Acute respiratory distress syndrome]]||Treatment||–||Ventilator Strategies by VILI Mechanisms
|-
| Pulmonary||[[Acute respiratory distress syndrome]]||Prognosis||–||–
|-
| Pulmonary||[[Sepsis]]||Definitions||–||Sepsis Definitions
|-
| Pulmonary||[[Sepsis]]||Fluids & vasoactive drugs||–||–
|-
| Pulmonary||[[Sepsis]]||Antibiotics||–||–
|-
| Pulmonary||[[Sepsis]]||Steroids||–||–
|-
| Pulmonary||[[Sepsis]]||Activated protein C||–||–
|-
| Pulmonary||[[Sepsis]]||Intensive glycemic control||–||–
|-
| Gastroenterology||[[Dysphagia]]||Definitions||Etiologies of and approach to dysphagia||–
|-
| Gastroenterology||[[Achalasia]]||Achalasia||–||–
|-
| Gastroenterology||[[Other esophageal disorders]]||Other esophageal disorders||–||–
|-
| Gastroenterology||[[Gastroesophageal reflux disease]]||Pathophysiology||–||–
|-
| Gastroenterology||[[Gastroesophageal reflux disease]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Gastroesophageal reflux disease]]||Diagnosis||–||–
|-
| Gastroenterology||[[Gastroesophageal reflux disease]]||Treatment||–||–
|-
| Gastroenterology||[[Gastroesophageal reflux disease]]||Complications||–||–
|-
| Gastroenterology||[[Dyspepsia]]||Definition||–||–
|-
| Gastroenterology||[[Dyspepsia]]||Etiologies||–||–
|-
| Gastroenterology||[[Dyspepsia]]||Treatment of functional dyspepsia||–||–
|-
| Gastroenterology||[[Peptic ulcer disease]]||Epidemiology & etiologies||–||–
|-
| Gastroenterology||[[Peptic ulcer disease]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Peptic ulcer disease]]||Diagnostic studies||–||–
|-
| Gastroenterology||[[Peptic ulcer disease]]||Treatment||–||–
|-
| Gastroenterology||[[Peptic ulcer disease]]||Prophylaxis if ASA/NSAID required||–||–
|-
| Gastroenterology||[[Gastrointestinal bleeding]]||Definition||–||–
|-
| Gastroenterology||[[Gastrointestinal bleeding]]||Etiologies of upper GI bleed (UGIB)||–||–
|-
| Gastroenterology||[[Gastrointestinal bleeding]]||Etiologies of lower GI bleed (LGIB)||–||–
|-
| Gastroenterology||[[Gastrointestinal bleeding]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Gastrointestinal bleeding]]||Initial management||–||–
|-
| Gastroenterology||[[Gastrointestinal bleeding]]||Workup||–||–
|-
| Gastroenterology||[[Gastrointestinal bleeding]]||Diagnostic studies||–||–
|-
| Gastroenterology||[[Gastrointestinal bleeding]]||Treatment of GIB by Etiologies||–||Treatment of GIB by Etiologies
|-
| Gastroenterology||[[Gastrointestinal bleeding]]||Obscure GIB||–||–
|-
| Gastroenterology||[[Acute diarrhea]]||Infectious Etiologies of Acute Diarrhea||–||Infectious Etiologies of Acute Diarrhea
|-
| Gastroenterology||[[Acute diarrhea]]||Evaluation||–||–
|-
| Gastroenterology||[[Acute diarrhea]]||Treatment||–||–
|-
| Gastroenterology||[[Clostridium difficile-associated diarrhea]]||Pathogenesis||–||–
|-
| Gastroenterology||[[Clostridium difficile-associated diarrhea]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Clostridium difficile-associated diarrhea]]||Diagnosis||–||–
|-
| Gastroenterology||[[Clostridium difficile-associated diarrhea]]||Treatment||–||–
|-
| Gastroenterology||[[Chronic diarrhea]]||Medications||–||–
|-
| Gastroenterology||[[Chronic diarrhea]]||Osmotic||–||–
|-
| Gastroenterology||[[Chronic diarrhea]]||Malabsorption||–||–
|-
| Gastroenterology||[[Chronic diarrhea]]||Inflammatory||–||–
|-
| Gastroenterology||[[Chronic diarrhea]]||Secretory||–||–
|-
| Gastroenterology||[[Chronic diarrhea]]||Motility||–||–
|-
| Gastroenterology||[[Chronic diarrhea]]||Workup of chronic diarrhea||Workup of chronic diarrhea||–
|-
| Gastroenterology||[[Constipation and adynamic ileus]]||Constipation||–||–
|-
| Gastroenterology||[[Constipation and adynamic ileus]]||Acute pseudo-obstruction (adynamic ileus)||–||–
|-
| Gastroenterology||[[Nutrition in hospitalized patients]]||Pathophysiology||–||–
|-
| Gastroenterology||[[Nutrition in hospitalized patients]]||Critical illness||–||–
|-
| Gastroenterology||[[Nutrition in hospitalized patients]]||End-stage liver disease||–||–
|-
| Gastroenterology||[[Nutrition in hospitalized patients]]||Refeeding syndrome||–||–
|-
| Gastroenterology||[[Diverticulosis]]||Definition & pathobiology||–||–
|-
| Gastroenterology||[[Diverticulosis]]||Epidemiology||–||–
|-
| Gastroenterology||[[Diverticulosis]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Diverticulitis]]||Pathophysiology||–||–
|-
| Gastroenterology||[[Diverticulitis]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Diverticulitis]]||Diagnostic studies||–||–
|-
| Gastroenterology||[[Diverticulitis]]||Treatment||–||–
|-
| Gastroenterology||[[Diverticulitis]]||Prevention||–||–
|-
| Gastroenterology||[[Diverticular hemorrhage]]||Pathophysiology||–||–
|-
| Gastroenterology||[[Diverticular hemorrhage]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Diverticular hemorrhage]]||Diagnostic studies||–||–
|-
| Gastroenterology||[[Diverticular hemorrhage]]||Treatment||–||–
|-
| Gastroenterology||[[Inflammatory bowel disease]]||Definition||–||–
|-
| Gastroenterology||[[Inflammatory bowel disease]]||Epidemiology & pathophysiology||–||–
|-
| Gastroenterology||[[Ulcerative colitis]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Ulcerative colitis]]||Diagnosis||–||–
|-
| Gastroenterology||[[Ulcerative colitis]]||Complications||–||–
|-
| Gastroenterology||[[Ulcerative colitis]]||Prognosis||–||–
|-
| Gastroenterology||[[Crohn's disease]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Crohn's disease]]||Diagnosis||–||–
|-
| Gastroenterology||[[Crohn's disease]]||Complications||–||–
|-
| Gastroenterology||[[Crohn's disease]]||Prognosis||–||–
|-
| Gastroenterology||[[Management of inflammatory bowel disease]]||Initial evaluation||–||IBD Induction of Remission
|-
| Gastroenterology||[[Management of inflammatory bowel disease]]||Goals of treatment||–||IBD Maintenance of Remission
|-
| Gastroenterology||[[Management of inflammatory bowel disease]]||Complications of therapy||–||–
|-
| Gastroenterology||[[Management of inflammatory bowel disease]]||Cancer screening||–||–
|-
| Gastroenterology||[[Acute mesenteric ischemia]]||Etiologies||–||–
|-
| Gastroenterology||[[Acute mesenteric ischemia]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Acute mesenteric ischemia]]||Physical exam||–||–
|-
| Gastroenterology||[[Acute mesenteric ischemia]]||Diagnostic studies||–||–
|-
| Gastroenterology||[[Acute mesenteric ischemia]]||Treatment||–||–
|-
| Gastroenterology||[[Acute mesenteric ischemia]]||Prognosis||–||–
|-
| Gastroenterology||[[Ischemic colitis]]||Definition & pathophysiology||–||–
|-
| Gastroenterology||[[Ischemic colitis]]||Clinical manifestations, diagnosis, & treatment||–||–
|-
| Gastroenterology||[[Pancreatitis]]||Pathogenesis||–||–
|-
| Gastroenterology||[[Pancreatitis]]||Etiologies||–||–
|-
| Gastroenterology||[[Pancreatitis]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Pancreatitis]]||Physical exam||–||–
|-
| Gastroenterology||[[Pancreatitis]]||Diagnostic studies||–||–
|-
| Gastroenterology||[[Pancreatitis]]||Treatment||–||–
|-
| Gastroenterology||[[Pancreatitis]]||Complications||–||Ranson's Criteria
|-
| Gastroenterology||[[Pancreatitis]]||Prognosis||–||Pancreatitis Prognosis by Ranson's Criteria
|-
| Gastroenterology||[[Pancreatitis]]||Chronic Pancreatitis||–||–
|-
| Gastroenterology||[[Abnormal liver tests]]||Tests of hepatocellular injury or cholestasis||–||–
|-
| Gastroenterology||[[Abnormal liver tests]]||Tests of hepatic function||–||–
|-
| Gastroenterology||[[Abnormal liver tests]]||Patterns of liver injury||–||–
|-
| Gastroenterology||[[Abnormal liver tests]]||Abnormal liver tests with hepatocellular pattern||Approach to abnormal liver tests with hepatocellular pattern||–
|-
| Gastroenterology||[[Abnormal liver tests]]||Abnormal liver tests with cholestatic pattern||Approach to abnormal liver tests with cholestatic pattern||–
|-
| Gastroenterology||[[Abnormal liver tests]]||Abnormal liver tests with isolated hyperbilirubinemia||Approach to abnormal liver tests with isolated hyperbilirubinemia||–
|-
| Gastroenterology||[[Abnormal liver tests]]||Abnormal liver tests with infiltrated pattern||Approach to abnormal liver tests with infiltrated pattern||–
|-
| Gastroenterology||[[Abnormal liver tests]]||Abnormal liver tests in asymptomatic patients||–||–
|-
| Gastroenterology||[[Abnormal liver tests]]||Common medications that cause abnormal liver tests||–||Common medications that cause abnormal liver tests
|-
| Gastroenterology||[[Viral hepatitis]]||Hepatitis A||–||–
|-
| Gastroenterology||[[Viral hepatitis]]||Hepatitis B||Serologic Diagnosis of Hepatitis B||–
|-
| Gastroenterology||[[Viral hepatitis]]||Hepatitis B||–||Serology of Hepatitis B
|-
| Gastroenterology||[[Viral hepatitis]]||Hepatitis C||–||–
|-
| Gastroenterology||[[Viral hepatitis]]||Hepatitis D||–||–
|-
| Gastroenterology||[[Viral hepatitis]]||Hepatitis E||–||–
|-
| Gastroenterology||[[Viral hepatitis]]||Other Viruses||–||–
|-
| Gastroenterology||[[Autoimmune hepatitis]]||Classification||–||–
|-
| Gastroenterology||[[Autoimmune hepatitis]]||Diagnosis and treatment||–||–
|-
| Gastroenterology||[[Other causes of hepatitis or hepatotoxicity]]||Alcoholic hepatitis||–||–
|-
| Gastroenterology||[[Other causes of hepatitis or hepatotoxicity]]||Acetaminophen hepatotoxicity||–||–
|-
| Gastroenterology||[[Other causes of hepatitis or hepatotoxicity]]||Ischemic hepatitis||–||–
|-
| Gastroenterology||[[Other causes of hepatitis or hepatotoxicity]]||Nonalcoholic fatty liver disease||–||–
|-
| Gastroenterology||[[Acute liver failure]]||Definition||–||–
|-
| Gastroenterology||[[Acute liver failure]]||Etiology||–||–
|-
| Gastroenterology||[[Acute liver failure]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Acute liver failure]]||Workup||–||–
|-
| Gastroenterology||[[Acute liver failure]]||Treatment||–||–
|-
| Gastroenterology||[[Acute liver failure]]||Prognosis||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Definition||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Etiologies||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Physical exam||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Laboratory studies||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Workup||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Ascites||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Spontaneous bacterial peritonitis||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Gastroesophageal varices ± UGIB||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Portosystemic encephalopathy (PSE)||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Hepatorenal syndrome (HRS)||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Hepatocellular carcinoma (HCC)||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Other complications||–||–
|-
| Gastroenterology||[[Cirrhosis]]||Prognosis||–||Modified Child-Turcotte-Pugh Scoring System
|-
| Gastroenterology||[[Cirrhosis]]||Liver transplantation||–||–
|-
| Gastroenterology||[[Other etiologies of cirrhosis]]||Hemochromatosis||–||–
|-
| Gastroenterology||[[Other etiologies of cirrhosis]]||Wilson's disease||–||–
|-
| Gastroenterology||[[Other etiologies of cirrhosis]]||ɑ1-antitrypsin deficiency||–||–
|-
| Gastroenterology||[[Other etiologies of cirrhosis]]||Primary biliary cirrhosis (PBC)||–||–
|-
| Gastroenterology||[[Other etiologies of cirrhosis]]||Primary sclerosing cholangitis (PSC)||–||–
|-
| Gastroenterology||[[Hepatic vascular disease]]||Portal vein thrombosis||–||–
|-
| Gastroenterology||[[Hepatic vascular disease]]||Budd-Chiari syndrome||–||–
|-
| Gastroenterology||[[Hepatic vascular disease]]||Sinusoidal obstruction syndrome||Hepatic vasculature||–
|-
| Gastroenterology||[[Ascites]]||Pathophysiology||–||Etiologies of Ascites
|-
| Gastroenterology||[[Ascites]]||Symptoms||–||–
|-
| Gastroenterology||[[Ascites]]||Evaluation||–||–
|-
| Gastroenterology||[[Ascites]]||Treatment||–||–
|-
| Gastroenterology||[[Ascites]]||Bacterial peritonitis||–||Ascites in Bacterial peritonitis
|-
| Gastroenterology||[[Cholelithiasis]]||Epidemiology & pathogenesis||–||–
|-
| Gastroenterology||[[Cholelithiasis]]||Types of gallstones||–||–
|-
| Gastroenterology||[[Cholelithiasis]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Cholelithiasis]]||Diagnostic studies||–||–
|-
| Gastroenterology||[[Cholelithiasis]]||Treatment||–||–
|-
| Gastroenterology||[[Cholelithiasis]]||Complications||–||–
|-
| Gastroenterology||[[Cholecystitis]]||Pathogenesis||–||–
|-
| Gastroenterology||[[Cholecystitis]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Cholecystitis]]||Diagnostic studies||–||–
|-
| Gastroenterology||[[Cholecystitis]]||Treatment||–||–
|-
| Gastroenterology||[[Cholecystitis]]||Complications||–||–
|-
| Gastroenterology||[[Choledocholithiasis]]||Definition||–||–
|-
| Gastroenterology||[[Choledocholithiasis]]||Epidemiology||–||–
|-
| Gastroenterology||[[Choledocholithiasis]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Choledocholithiasis]]||Diagnostic studies||–||–
|-
| Gastroenterology||[[Choledocholithiasis]]||Treatment||–||–
|-
| Gastroenterology||[[Choledocholithiasis]]||Complications||–||–
|-
| Gastroenterology||[[Cholangitis]]||Definition & etiologies||–||–
|-
| Gastroenterology||[[Cholangitis]]||Clinical manifestations||–||–
|-
| Gastroenterology||[[Cholangitis]]||Diagnostic studies||–||–
|-
| Gastroenterology||[[Cholangitis]]||Treatment||–||–
|-
| Nephrology||[[Acid-base disturbances]]||Consequences of Severe Acid-Base Disturbances||–||Consequences of Severe Acid-Base Disturbances
|-
| Nephrology||[[Acid-base disturbances]]||Workup||–||Acid-Base Disturbances
|-
| Nephrology||[[Acid-base disturbances]]||Compensation for Acid-Base Disturbances||–||Compensation for Acid-Base Disturbances
|-
| Nephrology||[[Acid-base disturbances]]||Acid-base nomogram||Acid-base nomogram||–
|-
| Nephrology||[[Metabolic acidosis]]||Initial workup||Approach to metabolic acidosis||–
|-
| Nephrology||[[Metabolic acidosis]]||Etiologies of AG metabolic acidosis||–||Etiologies of AG metabolic acidosis
|-
| Nephrology||[[Metabolic acidosis]]||Workup for AG metabolic acidosis||–||Manifestations of ingestions causing AG metabolic acidosis
|-
| Nephrology||[[Metabolic acidosis]]||Workup for non-AG metabolic acidosis ||–||Etiologies of non-AG metabolic acidosis
|-
| Nephrology||[[Metabolic acidosis]]||Renal tubular acidosis||–||Renal tubular acidosis
|-
| Nephrology||[[Metabolic acidosis]]||Treatment of severe metabolic acidosis||–||–
|-
| Nephrology||[[Metabolic alkalosis]]||Pathophysiology||–||–
|-
| Nephrology||[[Metabolic alkalosis]]||Workup||Approach to metabolic alkalosis||–
|-
| Nephrology||[[Metabolic alkalosis]]||Etiologies of metabolic alkalosis||–||Etiologies of metabolic alkalosis
|-
| Nephrology||[[Metabolic alkalosis]]||Treatment of severe metabolic alkalosis||–||–
|-
| Nephrology||[[Respiratory acidosis]]||Respiratory Acidosis||–||–
|-
| Nephrology||[[Respiratory alkalosis]]||Respiratory Alkalosis||–||–
|-
| Nephrology||[[Hyponatremia]]||Pathophysiology||Approach to hyponatremia||–
|-
| Nephrology||[[Hyponatremia]]||Workup||–||–
|-
| Nephrology||[[Hyponatremia]]||Hypovolemic hypotonic hyponatremia ||–||–
|-
| Nephrology||[[Hyponatremia]]||Euvolemic hypotonic hyponatremia||–||–
|-
| Nephrology||[[Hyponatremia]]||Hypervolemic hypotonic hyponatremia||–||–
|-
| Nephrology||[[Hyponatremia]]||Treatment||–||–
|-
| Nephrology||[[Hypernatremia]]||Pathophysiology||Approach to hypernatremia||–
|-
| Nephrology||[[Hypernatremia]]||Workup||–||–
|-
| Nephrology||[[Hypernatremia]]||Extrarenal H2O loss||–||–
|-
| Nephrology||[[Hypernatremia]]||Renal H2O loss||–||–
|-
| Nephrology||[[Hypernatremia]]||Other||–||–
|-
| Nephrology||[[Hypernatremia]]||Treatment||–||–
|-
| Nephrology||[[Polyuria]]||Definition and pathophysiology||Approach to polyuria||–
|-
| Nephrology||[[Polyuria]]||Workup||–||–
|-
| Nephrology||[[Polyuria]]||Osmotic diuresis||–||–
|-
| Nephrology||[[Polyuria]]||Water diuresis||–||–
|-
| Nephrology||[[Polyuria]]||Treatment||–||–
|-
| Nephrology||[[Hypokalemia]]||Transcellular shifts||Approach to hypokalemia||–
|-
| Nephrology||[[Hypokalemia]]||GI potassium losses||–||–
|-
| Nephrology||[[Hypokalemia]]||Renal potassium losses||–||–
|-
| Nephrology||[[Hypokalemia]]||Clinical manifestations||–||–
|-
| Nephrology||[[Hypokalemia]]||Workup||–||–
|-
| Nephrology||[[Hypokalemia]]||Treatment||–||–
|-
| Nephrology||[[Hyperkalemia]]||Transcellular shifts||–||–
|-
| Nephrology||[[Hyperkalemia]]||Decreased GFR||–||–
|-
| Nephrology||[[Hyperkalemia]]||Normal GFR but with Ø renal K excretion||–||–
|-
| Nephrology||[[Hyperkalemia]]||Clinical manifestations||–||–
|-
| Nephrology||[[Hyperkalemia]]||Workup||–||Treatment of Hyperkalemia
|-
| Nephrology||[[Acute kidney injury]]||Definition||–||–
|-
| Nephrology||[[Acute kidney injury]]||Workup||–||Etiologies and Diagnosis of Acute Kidney Injury
|-
| Nephrology||[[Acute kidney injury]]||Contrast-induced acute kidney injury (CIAKI)||–||–
|-
| Nephrology||[[Acute kidney injury]]||Treatment||–||–
|-
| Nephrology||[[Chronic kidney disease]]||Definition and etiologies||–||Stages of CKD
|-
| Nephrology||[[Chronic kidney disease]]||Treatment||–||Signs and Symptoms of Uremia
|-
| Nephrology||[[Diuresis]]||General considerations||–||Approach to Diuresis
|-
| Nephrology||[[Diuresis]]||Loop diuretics||–||–
|-
| Nephrology||[[Diuresis]]||Thiazide diuretics||–||–
|-
| Nephrology||[[Diuresis]]||K-sparing diuretics||–||–
|-
| Nephrology||[[Diuresis]]||Disease state specific regimens||–||–
|-
| Nephrology||[[Diuresis]]||Adverse effects||–||–
|-
| Nephrology||[[Renal replacement and dialysis]]||General||–||–
|-
| Nephrology||[[Renal replacement and dialysis]]||Hemodialysis (HD)||–||–
|-
| Nephrology||[[Renal replacement and dialysis]]||Continuous veno-venous hemofiltration (CVVH)||–||–
|-
| Nephrology||[[Renal replacement and dialysis]]||Peritoneal dialysis (PD)||–||–
|-
| Nephrology||[[Renal replacement and dialysis]]||Kidney transplantation||–||–
|-
| Nephrology||[[Glomerulonephritis]]||Definition||Approach to glomerulonephritis||–
|-
| Nephrology||[[Glomerulonephritis]]||ANCA-Positive Vasculitis||–||ANCA-Positive Vasculitis
|-
| Nephrology||[[Glomerulonephritis]]||Anti-GBM Disease||–||Anti-GBM Disease
|-
| Nephrology||[[Glomerulonephritis]]||Immune Complex Disease||–||Immune Complex Disease
|-
| Nephrology||[[Glomerulonephritis]]||Workup||–||–
|-
| Nephrology||[[Glomerulonephritis]]||Treatment||–||–
|-
| Nephrology||[[Asymptomatic glomerular hematuria]]||Definition and etiologies||–||–
|-
| Nephrology||[[Asymptomatic glomerular hematuria]]||IgA nephropathy||–||–
|-
| Nephrology||[[Nephrotic syndrome]]||Definition||–||–
|-
| Nephrology||[[Nephrotic syndrome]]||Primary glomerular diseases||–||–
|-
| Nephrology||[[Nephrotic syndrome]]||Systemic diseases||–||–
|-
| Nephrology||[[Nephrotic syndrome]]||Workup||–||–
|-
| Nephrology||[[Nephrotic syndrome]]||Treatment||–||–
|-
| Nephrology||[[Urinalysis]]||Urine Dipstick||–||Urine Dipstick
|-
| Nephrology||[[Urinalysis]]||Urine Sediment||–||Urine Sediment
|-
| Nephrology||[[Proteinuria]]||Proteinuria||–||Etiologies of Proteinuria
|-
| Nephrology||[[Hematuria]]||Workup||–||Etiologies of Hematuria
|-
| Nephrology||[[Nephrolithiasis]]||Types of stones and risk factors||–||–
|-
| Nephrology||[[Nephrolithiasis]]||Clinical manifestations||–||–
|-
| Nephrology||[[Nephrolithiasis]]||Workup||–||–
|-
| Nephrology||[[Nephrolithiasis]]||Acute treatment||–||–
|-
| Nephrology||[[Nephrolithiasis]]||Chronic treatment||–||–
|-
| Hematology-Oncology||[[Anemia]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Anemia]]||Diagnostic evaluation||Approach to anemia||–
|-
| Hematology-Oncology||[[Microcytic anemia]]||Approach to microcytic anemias||Approach to microcytic anemias||–
|-
| Hematology-Oncology||[[Microcytic anemia]]||Iron deficiency ||–||–
|-
| Hematology-Oncology||[[Microcytic anemia]]||Thalassemias||–||–
|-
| Hematology-Oncology||[[Microcytic anemia]]||Anemia of chronic inflammation||–||–
|-
| Hematology-Oncology||[[Microcytic anemia]]||Sideroblastic anemia||–||–
|-
| Hematology-Oncology||[[Normocytic anemia]]||Pancytopenia||–||–
|-
| Hematology-Oncology||[[Normocytic anemia]]||Anemia of chronic inflammation||–||–
|-
| Hematology-Oncology||[[Normocytic anemia]]||Anemias of chronic disorders||–||–
|-
| Hematology-Oncology||[[Normocytic anemia]]||Sideroblastic anemia||–||–
|-
| Hematology-Oncology||[[Normocytic anemia]]||Pure red cell aplasia||–||–
|-
| Hematology-Oncology||[[Macrocytic anemia]]||Megaloblastic anemia||–||–
|-
| Hematology-Oncology||[[Macrocytic anemia]]||Folate deficiency||–||–
|-
| Hematology-Oncology||[[Macrocytic anemia]]||Vitamin B12 deficiency||–||–
|-
| Hematology-Oncology||[[Macrocytic anemia]]||Nonmegaloblastic macrocytic anemias||–||–
|-
| Hematology-Oncology||[[Pancytopenia]]||Etiologies||–||–
|-
| Hematology-Oncology||[[Pancytopenia]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Pancytopenia]]||Aplastic anemia||–||–
|-
| Hematology-Oncology||[[Pancytopenia]]||Myelodysplastic syndromes (MDS)||–||–
|-
| Hematology-Oncology||[[Pancytopenia]]||Paroxysmal nocturnal hemoglobinuria (PNH)||–||–
|-
| Hematology-Oncology||[[Pancytopenia]]||Myelophthisic anemia||–||–
|-
| Hematology-Oncology||[[Hemolytic anemia]]||Diagnostic evaluation||–||Causes of Hemolytic Anemia by Mechanism
|-
| Hematology-Oncology||[[Hemolytic anemia]]||Glucose-6-phosphate dehydrogenase (G6PD) deficiency||–||–
|-
| Hematology-Oncology||[[Hemolytic anemia]]||Sickle cell anemia||–||–
|-
| Hematology-Oncology||[[Hemolytic anemia]]||Hereditary spherocytosis (HS)||–||–
|-
| Hematology-Oncology||[[Hemolytic anemia]]||Autoimmune hemolytic anemia (AIHA)||–||–
|-
| Hematology-Oncology||[[Hemolytic anemia]]||Drug-induced hemolytic anemia||–||–
|-
| Hematology-Oncology||[[Hemolytic anemia]]||Microangiopathic hemolytic anemia (MAHA)||–||–
|-
| Hematology-Oncology||[[Hemolytic anemia]]||Hypersplenism||–||Causes of Splenomegaly
|-
| Hematology-Oncology||[[Disorders of hemostasis]]||Approach to abnormal hemostasis||Approach to abnormal hemostasis||–
|-
| Hematology-Oncology||[[Disorders of hemostasis]]||Clinical Characteristics of Bleeding Disorders||–||Clinical Characteristics of Bleeding Disorders
|-
| Hematology-Oncology||[[Disorders of hemostasis]]||Coagulation Cascade||Coagulation Cascade||–
|-
| Hematology-Oncology||[[Disorders of hemostasis]]||Purpura||–||–
|-
| Hematology-Oncology||[[Thrombocytopenia]]||Etiologies||Approach to thrombocytopenia||–
|-
| Hematology-Oncology||[[Thrombocytopenia]]||Thrombocytopenia and Risk of Bleeding||–||Thrombocytopenia and Risk of Bleeding
|-
| Hematology-Oncology||[[Thrombocytopenia]]||Diagnostic evaluation||–||–
|-
| Hematology-Oncology||[[Thrombocytopenia]]||Primary immune thrombocytopenic purpura (ITP)||–||Treatment of Primary ITP in Adults
|-
| Hematology-Oncology||[[Thrombocytopenia]]||Heparin-Induced Thrombocytopenia||–||Overview of Heparin-Induced Thrombocytopenia
|-
| Hematology-Oncology||[[Thrombocytopenia]]||Evaluation of Suspected HIT||–||Evaluation of Suspected HIT
|-
| Hematology-Oncology||[[Thrombocytopenia]]||Hemolytic-uremic syndrome (HUS)||–||–
|-
| Hematology-Oncology||[[Thrombocytopenia]]||Thrombotic thrombocytopenic purpura (TTP)||–||–
|-
| Hematology-Oncology||[[Disorders of platelet function]]||Tests of platelet function||–||Mechanisms and Etiologies of Platelet Function Abnormalities
|-
| Hematology-Oncology||[[Disorders of platelet function]]||von Willebrand’s disease (vWD)||–||–
|-
| Hematology-Oncology||[[Disorders of platelet function]]||Uremic bleeding||–||–
|-
| Hematology-Oncology||[[Coagulopathies]]||Screening Test Abnormalities in Inherited and Acquired Coagulopathies||–||Screening Test Abnormalities in Inherited and Acquired Coagulopathies
|-
| Hematology-Oncology||[[Coagulopathies]]||Further coagulation tests||–||–
|-
| Hematology-Oncology||[[Coagulopathies]]||Hemophilias||–||–
|-
| Hematology-Oncology||[[Coagulopathies]]||Coagulation factor inhibitors||–||–
|-
| Hematology-Oncology||[[Coagulopathies]]||Disseminated intravascular coagulation (DIC)||–||–
|-
| Hematology-Oncology||[[Coagulopathies]]||Vitamin K deficiency||–||Properties and Antidotes for Anticoagulants and Fibrinolytics
|-
| Hematology-Oncology||[[Hypercoagulable states]]||Inherited Hypercoagulable States||–||Inherited Hypercoagulable States
|-
| Hematology-Oncology||[[Hypercoagulable states]]||Vascular Beds Affected by Inherited and Acquired Hypercoagulable States||–||Vascular Beds Affected by Inherited and Acquired Hypercoagulable States
|-
| Hematology-Oncology||[[Hypercoagulable states]]||Diagnostic evaluation||–||–
|-
| Hematology-Oncology||[[Hypercoagulable states]]||Treatment||–||–
|-
| Hematology-Oncology||[[Hypercoagulable states]]||Antiphospholipid syndrome (APS)||–||–
|-
| Hematology-Oncology||[[Disorders of leukocytes]]||Neutrophilia||–||Neutrophilia
|-
| Hematology-Oncology||[[Disorders of leukocytes]]||Neutropenia||–||Neutropenia
|-
| Hematology-Oncology||[[Disorders of leukocytes]]||Lymphocytosis||–||Lymphocytosis
|-
| Hematology-Oncology||[[Disorders of leukocytes]]||Monocytosis||–||Monocytosis
|-
| Hematology-Oncology||[[Disorders of leukocytes]]||Eosinophilia||–||Eosinophilia
|-
| Hematology-Oncology||[[Disorders of leukocytes]]||Basophilia||–||Basophilia
|-
| Hematology-Oncology||[[Disorders of leukocytes]]||Lymphadenopathy||–||Lymphadenopathy
|-
| Hematology-Oncology||[[Transfusion therapy]]||Blood Products and Indications||–||Blood Products and Indications
|-
| Hematology-Oncology||[[Transfusion therapy]]||Transfusion Complications||–||Transfusion Complications
|-
| Hematology-Oncology||[[Transfusion therapy]]||Transfusion Reactions||–||Transfusion Reactions
|-
| Hematology-Oncology||[[Myelodysplastic syndromes]]||Myeloid neoplasm overview||–||WHO 2008 Myeloid Neoplasm Categories
|-
| Hematology-Oncology||[[Myelodysplastic syndromes]]||Myelodysplastic syndromes (MDS) overview||–||WHO 2008 Classification Systems for MDS
|-
| Hematology-Oncology||[[Myelodysplastic syndromes]]||Revised International Prognostic Scoring System||–||Revised International Prognostic Scoring System for AML
|-
| Hematology-Oncology||[[Myeloproliferative neoplasms (mpn)]]||Myeloproliferative Neoplasms (MPN)||–||–
|-
| Hematology-Oncology||[[Polycythemia vera (pv)]]||Definition||–||–
|-
| Hematology-Oncology||[[Polycythemia vera (pv)]]||Etiologies of erythrocytosis||–||–
|-
| Hematology-Oncology||[[Polycythemia vera (pv)]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Polycythemia vera (pv)]]||Diagnostic evaluation||–||–
|-
| Hematology-Oncology||[[Polycythemia vera (pv)]]||Treatment||–||–
|-
| Hematology-Oncology||[[Polycythemia vera (pv)]]||Prognosis||–||–
|-
| Hematology-Oncology||[[Essential thrombocythemia (et)]]||Definition||–||–
|-
| Hematology-Oncology||[[Essential thrombocythemia (et)]]||Etiologies of thrombocytosis||–||–
|-
| Hematology-Oncology||[[Essential thrombocythemia (et)]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Essential thrombocythemia (et)]]||Diagnostic evaluation||–||–
|-
| Hematology-Oncology||[[Essential thrombocythemia (et)]]||Prognosis||–||–
|-
| Hematology-Oncology||[[Primary myelofibrosis (pmf)]]||Definition||–||–
|-
| Hematology-Oncology||[[Primary myelofibrosis (pmf)]]||Etiologies of myelofibrosis||–||–
|-
| Hematology-Oncology||[[Primary myelofibrosis (pmf)]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Primary myelofibrosis (pmf)]]||Diagnostic evaluation||–||–
|-
| Hematology-Oncology||[[Primary myelofibrosis (pmf)]]||Treatment||–||–
|-
| Hematology-Oncology||[[Primary myelofibrosis (pmf)]]||Complications and prognosis||–||–
|-
| Hematology-Oncology||[[Acute leukemia]]||Definition||–||–
|-
| Hematology-Oncology||[[Acute leukemia]]||Epidemiology and risk factors||–||–
|-
| Hematology-Oncology||[[Acute leukemia]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Acute leukemia]]||Diagnostic evaluation||–||–
|-
| Hematology-Oncology||[[Acute myelogenous leukemia (aml)]]||Classification||–||WHO 2008 Classification of AML
|-
| Hematology-Oncology||[[Acute myelogenous leukemia (aml)]]||Treatment||–||AML Genetics
|-
| Hematology-Oncology||[[Acute myelogenous leukemia (aml)]]||Prognosis||–||–
|-
| Hematology-Oncology||[[Acute myelogenous leukemia (aml)]]||Acute Promyelocytic Leukemia (APL)||–||–
|-
| Hematology-Oncology||[[Acute lymphoblastic leukemia (all)]]||Classification||–||WHO Immunophenotype Classification of ALL
|-
| Hematology-Oncology||[[Acute lymphoblastic leukemia (all)]]||Treatment||–||–
|-
| Hematology-Oncology||[[Acute lymphoblastic leukemia (all)]]||Prognosis||–||–
|-
| Hematology-Oncology||[[Chronic myelogenous leukemia (cml)]]||Definition||–||–
|-
| Hematology-Oncology||[[Chronic myelogenous leukemia (cml)]]||Epidemiology and risk factors||–||–
|-
| Hematology-Oncology||[[Chronic myelogenous leukemia (cml)]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Chronic myelogenous leukemia (cml)]]||Diagnostic evaluation||–||–
|-
| Hematology-Oncology||[[Chronic myelogenous leukemia (cml)]]||Treatment||–||Goals of TKI Therapy
|-
| Hematology-Oncology||[[Chronic myelogenous leukemia (cml)]]||Prognosis||–||–
|-
| Hematology-Oncology||[[Chronic lymphocytic leukemia (cll)]]||Definition||–||–
|-
| Hematology-Oncology||[[Chronic lymphocytic leukemia (cll)]]||Epidemiology and risk factors||–||–
|-
| Hematology-Oncology||[[Chronic lymphocytic leukemia (cll)]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Chronic lymphocytic leukemia (cll)]]||Diagnostic evaluation||–||CLL Staging
|-
| Hematology-Oncology||[[Chronic lymphocytic leukemia (cll)]]||Treatment||–||–
|-
| Hematology-Oncology||[[Chronic lymphocytic leukemia (cll)]]||Prognosis||–||–
|-
| Hematology-Oncology||[[Lymphoma]]||Definition||–||–
|-
| Hematology-Oncology||[[Lymphoma]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Lymphoma]]||Diagnostic and staging evaluation||–||Ann Arbor Staging System with Cotswolds Modifications
|-
| Hematology-Oncology||[[Hodgkin lymphoma (hl)]]||Epidemiology and risk factors||–||–
|-
| Hematology-Oncology||[[Hodgkin lymphoma (hl)]]||Pathology||–||WHO Histologic Classification of Classical HL
|-
| Hematology-Oncology||[[Hodgkin lymphoma (hl)]]||Treatment||–||International Prognostic Score (IPS)
|-
| Hematology-Oncology||[[Non-hodgkin lymphoma (nhl)]]||Epidemiology and risk factors||–||WHO Classification of Lymphoid Malignancies
|-
| Hematology-Oncology||[[Non-hodgkin lymphoma (nhl)]]||Treatment||–||–
|-
| Hematology-Oncology||[[Non-hodgkin lymphoma (nhl)]]||Prognosis||–||Follicular Lymphoma International Prognostic Index (FLIPI)
|-
| Hematology-Oncology||[[Non-hodgkin lymphoma (nhl)]]||HIV-associated NHL||–||International Prognostic Index (IPI) for Aggressive NHL
|-
| Hematology-Oncology||[[Multiple myeloma]]||Definition and epidemiology||–||–
|-
| Hematology-Oncology||[[Multiple myeloma]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Multiple myeloma]]||Diagnostic and staging evaluation||–||Multiple Myeloma Staging Systems
|-
| Hematology-Oncology||[[Multiple myeloma]]||Treatment||–||–
|-
| Hematology-Oncology||[[Monoclonal gammopathy of uncertain significance]]||Definition and epidemiology||–||–
|-
| Hematology-Oncology||[[Monoclonal gammopathy of uncertain significance]]||Management||–||–
|-
| Hematology-Oncology||[[Monoclonal gammopathy of uncertain significance]]||Prognosis||–||–
|-
| Hematology-Oncology||[[Waldenstrom's macroglobulinemia]]||Definition||–||–
|-
| Hematology-Oncology||[[Waldenstrom's macroglobulinemia]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Waldenstrom's macroglobulinemia]]||Diagnostic evaluation||–||–
|-
| Hematology-Oncology||[[Waldenstrom's macroglobulinemia]]||Treatment||–||–
|-
| Hematology-Oncology||[[Hematopoietic stem cell transplantation]]||Indications||–||Categories of Stem Cell Transplantation
|-
| Hematology-Oncology||[[Hematopoietic stem cell transplantation]]||Transplantation procedure||–||Prophylaxis and Supportive Medications during HSCT
|-
| Hematology-Oncology||[[Hematopoietic stem cell transplantation]]||Complications||–||Timing of Complications following Allogeneic HSCT
|-
| Hematology-Oncology||[[Lung cancer]]||Pathology and Genetics of Lung Cancer||–||Pathology and Genetics of Lung Cancer
|-
| Hematology-Oncology||[[Lung cancer]]||Epidemiology and risk factors||–||–
|-
| Hematology-Oncology||[[Lung cancer]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Lung cancer]]||Screening||–||–
|-
| Hematology-Oncology||[[Lung cancer]]||Diagnostic and staging evaluation||–||TNM Staging System for NSCLC
|-
| Hematology-Oncology||[[Lung cancer]]||NSCLC Treatment||–||NSCLC Simplified Staging Schema
|-
| Hematology-Oncology||[[Lung cancer]]||SCLC Treatment||–||–
|-
| Hematology-Oncology||[[Breast cancer]]||Epidemiology and genetics||–||–
|-
| Hematology-Oncology||[[Breast cancer]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Breast cancer]]||Screening||–||–
|-
| Hematology-Oncology||[[Breast cancer]]||Diagnostic evaluation||–||–
|-
| Hematology-Oncology||[[Breast cancer]]||Staging||–||Simplified Staging System for Breast Cancer
|-
| Hematology-Oncology||[[Breast cancer]]||Treatment||–||Treatment of Carcinoma in situ and Invasive Carcinoma of the Breast
|-
| Hematology-Oncology||[[Breast cancer]]||Prevention||–||–
|-
| Hematology-Oncology||[[Prostate cancer]]||Epidemiology and risk factors||–||–
|-
| Hematology-Oncology||[[Prostate cancer]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Prostate cancer]]||Screening||–||–
|-
| Hematology-Oncology||[[Prostate cancer]]||Diagnostic and staging evaluation||–||TNM Staging and Treatment of Prostate Cancer
|-
| Hematology-Oncology||[[Prostate cancer]]||Prognosis||–||–
|-
| Hematology-Oncology||[[Prostate cancer]]||Prevention||–||–
|-
| Hematology-Oncology||[[Colorectal cancer]]||Epidemiology and risk factors||–||–
|-
| Hematology-Oncology||[[Colorectal cancer]]||Pathology and genetics||–||–
|-
| Hematology-Oncology||[[Colorectal cancer]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Colorectal cancer]]||Screening||–||–
|-
| Hematology-Oncology||[[Colorectal cancer]]||Staging||–||Treatment Based on TNM and Modified Dukes Staging of Colorectal Cancer
|-
| Hematology-Oncology||[[Chemotherapy side effects]]||Chemotherapy Side Effects||–||Select Adverse Effects from Chemotherapy
|-
| Hematology-Oncology||[[Pancreatic tumors]]||Pathology and genetics||–||–
|-
| Hematology-Oncology||[[Pancreatic tumors]]||Epidemiology and risk factors||–||–
|-
| Hematology-Oncology||[[Pancreatic tumors]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Pancreatic tumors]]||Diagnostic and staging evaluation||–||Staging and Prognosis of Pancreatic Adenocarcinoma
|-
| Hematology-Oncology||[[Pancreatic tumors]]||Treatment of pancreatic adenocarcinoma||–||–
|-
| Hematology-Oncology||[[Pancreatic tumors]]||Cystic lesions of the pancreas||–||–
|-
| Hematology-Oncology||[[Fever and neutropenia]]||Definition||–||–
|-
| Hematology-Oncology||[[Fever and neutropenia]]||Pathophysiology and microbiology||–||–
|-
| Hematology-Oncology||[[Fever and neutropenia]]||Prevention||–||–
|-
| Hematology-Oncology||[[Fever and neutropenia]]||Diagnostic evaluation||–||–
|-
| Hematology-Oncology||[[Fever and neutropenia]]||Risk stratification||–||–
|-
| Hematology-Oncology||[[Fever and neutropenia]]||Initial antibiotic therapy||–||–
|-
| Hematology-Oncology||[[Fever and neutropenia]]||Modification to initial antibiotic regimen||–||–
|-
| Hematology-Oncology||[[Fever and neutropenia]]||Duration of therapy||–||–
|-
| Hematology-Oncology||[[Fever and neutropenia]]||Role of hematopoietic growth factors||–||–
|-
| Hematology-Oncology||[[Spinal cord compression]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Spinal cord compression]]||Diagnostic evaluation||–||–
|-
| Hematology-Oncology||[[Spinal cord compression]]||Treatment||–||–
|-
| Hematology-Oncology||[[Tumor lysis syndrome]]||Clinical manifestations||–||–
|-
| Hematology-Oncology||[[Tumor lysis syndrome]]||Prophylaxis||–||–
|-
| Hematology-Oncology||[[Tumor lysis syndrome]]||Treatment||–||–
|-
| Hematology-Oncology||[[Cancer of unknown primary site]]||Cancer of Unknown Primary Site||–||Evaluation of Cancer of Unknown Primary Site
|-
| Infectious Diseases||[[Pneumonia]]||Microbiology of Pneumonia||–||Microbiology of Pneumonia
|-
| Infectious Diseases||[[Pneumonia]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Pneumonia]]||Diagnostic studies||–||–
|-
| Infectious Diseases||[[Pneumonia]]||Prognosis||–||–
|-
| Infectious Diseases||[[Pneumonia]]||Treatment||–||Treatment of Pneumonia
|-
| Infectious Diseases||[[Pneumonia]]||Prevention||–||–
|-
| Infectious Diseases||[[Viral respiratory infections]]||Microbiology & epidemiology||–||–
|-
| Infectious Diseases||[[Viral respiratory infections]]||Diagnosis||–||–
|-
| Infectious Diseases||[[Viral respiratory infections]]||Treatment||–||–
|-
| Infectious Diseases||[[Viral respiratory infections]]||Prevention||–||–
|-
| Infectious Diseases||[[Fungal infections]]||Candida species||–||Treatment of Candidiasis
|-
| Infectious Diseases||[[Fungal infections]]||Cryptococcus||–||–
|-
| Infectious Diseases||[[Fungal infections]]||Histoplasmosis||–||–
|-
| Infectious Diseases||[[Fungal infections]]||Coccidioidomycosis||–||–
|-
| Infectious Diseases||[[Fungal infections]]||Blastomycosis||–||–
|-
| Infectious Diseases||[[Fungal infections]]||Aspergillosis||–||–
|-
| Infectious Diseases||[[Fungal infections]]||Zygomycetes||–||–
|-
| Infectious Diseases||[[Fungal infections]]||Fungal diagnostics||–||–
|-
| Infectious Diseases||[[Infections in immunocompromised hosts]]||Classic Infectious Etiologies in Immunocompromised Hosts||–||Classic Infectious Etiologies in Immunocompromised Hosts
|-
| Infectious Diseases||[[Urinary tract infection]]||Definitions||–||–
|-
| Infectious Diseases||[[Urinary tract infection]]||Microbiology||–||–
|-
| Infectious Diseases||[[Urinary tract infection]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Urinary tract infection]]||Diagnostic studies||–||–
|-
| Infectious Diseases||[[Urinary tract infection]]||Treatment||–||Treatment of UTI
|-
| Infectious Diseases||[[Cellulitis]]||Microbiology & clinical||–||–
|-
| Infectious Diseases||[[Cellulitis]]||Diagnosis||–||Microbiology of Bite Infections
|-
| Infectious Diseases||[[Cellulitis]]||Treatment||–||Treatment of Cellulitis
|-
| Infectious Diseases||[[Other cutaneous infections]]||Other Cutaneous Infections||–||Other Cutaneous Infections
|-
| Infectious Diseases||[[Diabetic foot]]||Microbiology||–||–
|-
| Infectious Diseases||[[Diabetic foot]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Diabetic foot]]||Diagnostic studies||–||–
|-
| Infectious Diseases||[[Diabetic foot]]||Treatment||–||Treatment of Diabetic Foot
|-
| Infectious Diseases||[[Necrotizing fasciitis]]||Definition||–||–
|-
| Infectious Diseases||[[Necrotizing fasciitis]]||Epidemiology||–||–
|-
| Infectious Diseases||[[Necrotizing fasciitis]]||Microbiology||–||–
|-
| Infectious Diseases||[[Necrotizing fasciitis]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Necrotizing fasciitis]]||Diagnostic signs||–||–
|-
| Infectious Diseases||[[Necrotizing fasciitis]]||Treatment||–||–
|-
| Infectious Diseases||[[Necrotizing fasciitis]]||Prognosis||–||–
|-
| Infectious Diseases||[[Clostridial myonecrosis]]||Definition||–||–
|-
| Infectious Diseases||[[Clostridial myonecrosis]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Clostridial myonecrosis]]||Diagnostic signs||–||–
|-
| Infectious Diseases||[[Clostridial myonecrosis]]||Treatment||–||–
|-
| Infectious Diseases||[[Osteomyelitis]]||Microbiology||–||–
|-
| Infectious Diseases||[[Osteomyelitis]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Osteomyelitis]]||Diagnostic studies||–||–
|-
| Infectious Diseases||[[Osteomyelitis]]||Treatment||–||–
|-
| Infectious Diseases||[[Epidural abscess]]||Etiology||–||–
|-
| Infectious Diseases||[[Epidural abscess]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Epidural abscess]]||Diagnostic studies||–||–
|-
| Infectious Diseases||[[Epidural abscess]]||Treatment||–||–
|-
| Infectious Diseases||[[Acute bacterial meningitis]]||Definition||–||Microbiology in Adult Meningitis
|-
| Infectious Diseases||[[Acute bacterial meningitis]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Acute bacterial meningitis]]||Physical exam||–||–
|-
| Infectious Diseases||[[Acute bacterial meningitis]]||Diagnostic studies||–||–
|-
| Infectious Diseases||[[Acute bacterial meningitis]]||Recurrent meningitis||–||Typical CSF Findings in Meningitis
|-
| Infectious Diseases||[[Acute bacterial meningitis]]||Treatment||–||Treatment of Meningitis
|-
| Infectious Diseases||[[Acute bacterial meningitis]]||Prognosis||–||–
|-
| Infectious Diseases||[[Aseptic meningitis]]||Definition||–||–
|-
| Infectious Diseases||[[Aseptic meningitis]]||Etiologies||–||–
|-
| Infectious Diseases||[[Aseptic meningitis]]||Empiric treatment||–||–
|-
| Infectious Diseases||[[Encephalitis]]||Definition||–||–
|-
| Infectious Diseases||[[Encephalitis]]||Etiologies||–||–
|-
| Infectious Diseases||[[Encephalitis]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Encephalitis]]||Diagnostic studies||–||–
|-
| Infectious Diseases||[[Encephalitis]]||Treatment||–||–
|-
| Infectious Diseases||[[Bell's palsy]]||Definition & etiologies||–||–
|-
| Infectious Diseases||[[Bell's palsy]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Bell's palsy]]||Diagnosis||–||–
|-
| Infectious Diseases||[[Bell's palsy]]||Treatment||–||–
|-
| Infectious Diseases||[[Zoster]]||Definition & etiology||–||–
|-
| Infectious Diseases||[[Zoster]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Zoster]]||Diagnosis||–||–
|-
| Infectious Diseases||[[Zoster]]||Treatment||–||–
|-
| Infectious Diseases||[[Bacterial endocarditis]]||Definition||–||Microbiology of Endocarditis
|-
| Infectious Diseases||[[Bacterial endocarditis]]||Predisposing conditions||–||Modified Duke Criteria for Endocarditis
|-
| Infectious Diseases||[[Bacterial endocarditis]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Bacterial endocarditis]]||Physical exam||–||–
|-
| Infectious Diseases||[[Bacterial endocarditis]]||Diagnostic studies||–||–
|-
| Infectious Diseases||[[Bacterial endocarditis]]||Treatment||–||–
|-
| Infectious Diseases||[[Bacterial endocarditis]]||Indications for surgery||–||–
|-
| Infectious Diseases||[[Bacterial endocarditis]]||Prognosis||–||Endocarditis prophylaxis
|-
| Infectious Diseases||[[Bacteremia]]||Etiologies||–||–
|-
| Infectious Diseases||[[Bacteremia]]||Microbiology||–||–
|-
| Infectious Diseases||[[Bacteremia]]||Risk factors for true bacteremia ||–||–
|-
| Infectious Diseases||[[Bacteremia]]||Diagnosis||–||–
|-
| Infectious Diseases||[[Bacteremia]]||Treatment||–||–
|-
| Infectious Diseases||[[Tuberculosis]]||Epidemiology||–||–
|-
| Infectious Diseases||[[Tuberculosis]]||Microbiology & natural history||–||–
|-
| Infectious Diseases||[[Tuberculosis]]||Screening for prior infection||–||–
|-
| Infectious Diseases||[[Tuberculosis]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Tuberculosis]]||Diagnostic studies for active TB||–||–
|-
| Infectious Diseases||[[Tuberculosis]]||Preventive therapy||–||Prophylactic Regimen for TB
|-
| Infectious Diseases||[[Tuberculosis]]||Treatment of active tuberculosis||–||Antituberculous Medications
|-
| Infectious Diseases||[[Tuberculosis]]||Antituberculous Treatment Regimens||–||Antituberculous Treatment Regimens
|-
| Infectious Diseases||[[Hiv/aids]]||Definition||–||–
|-
| Infectious Diseases||[[Hiv/aids]]||Epidemiology||–||–
|-
| Infectious Diseases||[[Hiv/aids]]||Acute retroviral syndrome||–||–
|-
| Infectious Diseases||[[Hiv/aids]]||Diagnostic studies||–||–
|-
| Infectious Diseases||[[Hiv/aids]]||Approach to newly diagnosed HIV pt||–||Antiretrovirals and Side Effects
|-
| Infectious Diseases||[[Hiv/aids]]||Approach to previously established HIV pt||–||–
|-
| Infectious Diseases||[[Hiv/aids]]||Opportunistic infection prophylaxis||–||Opportunistic infection prophylaxis
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Fever||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Cutaneous||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Ophthalmologic||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Oral||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Endocrine/metabolic||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Cardiac||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Pulmonary||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Gastrointestinal & hepatobiliary||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Renal||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Hematologic/oncologic||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Neurologic||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Disseminated Mycobacterium avium complex||–||–
|-
| Infectious Diseases||[[Complications of hiv/aids]]||Cytomegalovirus||–||–
|-
| Infectious Diseases||[[Tick-borne illness]]||Distinguishing features of tick-borne illnesses||–||Distinguishing features of tick-borne illnesses
|-
| Infectious Diseases||[[Lyme disease]]||Microbiology||–||–
|-
| Infectious Diseases||[[Lyme disease]]||Epidemiology||–||–
|-
| Infectious Diseases||[[Lyme disease]]||Diagnostic studies||–||–
|-
| Infectious Diseases||[[Lyme disease]]||Treatment||–||–
|-
| Infectious Diseases||[[Rocky mountain spotted fever]]||Microbiology & epidemiology||–||–
|-
| Infectious Diseases||[[Rocky mountain spotted fever]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Rocky mountain spotted fever]]||Diagnosis||–||–
|-
| Infectious Diseases||[[Rocky mountain spotted fever]]||Treatment||–||–
|-
| Infectious Diseases||[[Ehrlichiosis/anaplasmosis]]||Microbiology||–||–
|-
| Infectious Diseases||[[Ehrlichiosis/anaplasmosis]]||Epidemiology||–||–
|-
| Infectious Diseases||[[Ehrlichiosis/anaplasmosis]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Ehrlichiosis/anaplasmosis]]||Diagnosis||–||–
|-
| Infectious Diseases||[[Ehrlichiosis/anaplasmosis]]||Treatment||–||–
|-
| Infectious Diseases||[[Babesiosis]]||Microbiology & epidemiology||–||–
|-
| Infectious Diseases||[[Babesiosis]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Babesiosis]]||Diagnosis||–||–
|-
| Infectious Diseases||[[Babesiosis]]||Treatment||–||–
|-
| Infectious Diseases||[[Tularemia]]||Microbiology||–||–
|-
| Infectious Diseases||[[Tularemia]]||Clinical manifestations||–||–
|-
| Infectious Diseases||[[Tularemia]]||Diagnosis & treatment||–||–
|-
| Infectious Diseases||[[Fever syndromes]]||Diagnosis approach||–||–
|-
| Infectious Diseases||[[Fever of unknown origin]]||Definition & etiologies||–||Etiologies of Classic FUO
|-
| Infectious Diseases||[[Fever of unknown origin]]||Workup||–||–
|-
| Infectious Diseases||[[Fever of unknown origin]]||Treatment||–||–
|-
| Infectious Diseases||[[Fever and rash]]||Approach to diagnostic workup||–||Possible Etiology
|-
| Infectious Diseases||[[Fever and rash]]||Treatment||–||–
|-
| Infectious Diseases||[[Fever in a returned traveler]]||Definition & etiologies||–||Common Etiologies of Fever in A Returned Traveler
|-
| Infectious Diseases||[[Fever in a returned traveler]]||Select clinical manifestations||–||–
|-
| Infectious Diseases||[[Fever in a returned traveler]]||Workup||–||–
|-
| Endocrinology||[[Hypopituitary syndromes]]||Panhypopituitarism||–||–
|-
| Endocrinology||[[Hyperpituitary syndromes]]||Pituitary tumors||–||–
|-
| Endocrinology||[[Hyperpituitary syndromes]]||Hyperprolactinemia||–||–
|-
| Endocrinology||[[Hyperpituitary syndromes]]||Acromegaly||–||–
|-
| Endocrinology||[[Hyperpituitary syndromes]]||Cushing's disease||–||–
|-
| Endocrinology||[[Hyperpituitary syndromes]]||Central hyperthyroidism||–||–
|-
| Endocrinology||[[Hyperpituitary syndromes]]||Multiple Endocrine Neoplasia Syndromes||–||Multiple Endocrine Neoplasia Syndromes
|-
| Endocrinology||[[Hyperpituitary syndromes]]||Polyglandular Autoimmune Syndromes||–||Polyglandular Autoimmune Syndromes
|-
| Endocrinology||[[Thyroid disorders]]||Diagnostic Studies in Thyroid Disorders||–||Diagnostic Studies in Thyroid Disorders
|-
| Endocrinology||[[Thyroid disorders]]||Approach to Thyroid Disorders||Approach to Thyroid Disorders||–
|-
| Endocrinology||[[Hypothyroidism]]||Etiologies||–||–
|-
| Endocrinology||[[Hypothyroidism]]||Hashimoto's thyroiditis||–||–
|-
| Endocrinology||[[Hypothyroidism]]||Clinical manifestations||–||–
|-
| Endocrinology||[[Hypothyroidism]]||Diagnostic studies||–||–
|-
| Endocrinology||[[Hypothyroidism]]||Treatment of overt hypothyroidism||–||–
|-
| Endocrinology||[[Hypothyroidism]]||Subclinical hypothyroidism||–||–
|-
| Endocrinology||[[Hyperthyroidism]]||Etiologies||–||–
|-
| Endocrinology||[[Hyperthyroidism]]||Clinical manifestations of hyperthyroidism||–||–
|-
| Endocrinology||[[Hyperthyroidism]]||Laboratory testing||–||–
|-
| Endocrinology||[[Hyperthyroidism]]||Graves' disease||–||–
|-
| Endocrinology||[[Hyperthyroidism]]||Thyroiditis||–||–
|-
| Endocrinology||[[Hyperthyroidism]]||Treatment||–||–
|-
| Endocrinology||[[Hyperthyroidism]]||Subclinical hyperthyroidism||–||–
|-
| Endocrinology||[[Nonthyroidal illness]]||Sick euthyroid syndrome||–||–
|-
| Endocrinology||[[Amiodarone and thyroid disease]]||Amiodarone-induced hypothyroidism||–||–
|-
| Endocrinology||[[Amiodarone and thyroid disease]]||Amiodarone-induced hyperthyroidism||–||–
|-
| Endocrinology||[[Thyroid nodules]]||Approach to thyroid nodules||Approach to thyroid nodules||–
|-
| Endocrinology||[[Cushing's syndrome]]||Definitions||–||–
|-
| Endocrinology||[[Cushing's syndrome]]||Etiologies of hypercortisolism||–||–
|-
| Endocrinology||[[Cushing's syndrome]]||Clinical manifestations||Approach to suspected Cushing's syndrome||–
|-
| Endocrinology||[[Cushing's syndrome]]||Treatment of Cushing's syndrome||–||–
|-
| Endocrinology||[[Hyperaldosteronism]]||Etiologies||–||–
|-
| Endocrinology||[[Hyperaldosteronism]]||Clinical manifestations||–||–
|-
| Endocrinology||[[Hyperaldosteronism]]||Diagnostic studies||Approach to suspected hyperaldosteronism||–
|-
| Endocrinology||[[Hyperaldosteronism]]||Treatment||–||–
|-
| Endocrinology||[[Adrenal insufficiency]]||Etiologies||–||–
|-
| Endocrinology||[[Adrenal insufficiency]]||Clinical manfiestations||–||–
|-
| Endocrinology||[[Adrenal insufficiency]]||Diagnostic studies||–||–
|-
| Endocrinology||[[Adrenal insufficiency]]||Adrenal insufficiency & critical illness||–||–
|-
| Endocrinology||[[Adrenal insufficiency]]||Treatment||–||–
|-
| Endocrinology||[[Pheochromocytoma]]||Clinical manifestations||–||–
|-
| Endocrinology||[[Pheochromocytoma]]||Diagnostic studies||–||–
|-
| Endocrinology||[[Pheochromocytoma]]||Treatment||–||–
|-
| Endocrinology||[[Adrenal incidentalomas]]||Epidemiology||–||–
|-
| Endocrinology||[[Adrenal incidentalomas]]||Differential diagnosis||–||–
|-
| Endocrinology||[[Adrenal incidentalomas]]||Workup||–||–
|-
| Endocrinology||[[Calcium disorders]]||Pitfalls in measuring calcium||–||Laboratory Findings in Calcium Disorders
|-
| Endocrinology||[[Hypercalcemia]]||Clinical manifestations||–||Etiologies of Hypercalcemia
|-
| Endocrinology||[[Hypercalcemia]]||Diagnostic studies||–||–
|-
| Endocrinology||[[Hypercalcemia]]||Treatment||–||Treatment of Hypercalcemia
|-
| Endocrinology||[[Hypercalcemia]]||Treatment of asymptomatic primary HPT||–||–
|-
| Endocrinology||[[Hypocalcemia]]||Clinical manifestations||–||Etiologies of Hypocalcemia
|-
| Endocrinology||[[Hypocalcemia]]||Diagnostic studies||–||–
|-
| Endocrinology||[[Hypocalcemia]]||Treatment||–||–
|-
| Endocrinology||[[Diabetes mellitus]]||Definition||–||–
|-
| Endocrinology||[[Diabetes mellitus]]||Categories||–||–
|-
| Endocrinology||[[Diabetes mellitus]]||Clinical manifestations||–||–
|-
| Endocrinology||[[Diabetes mellitus]]||Treatment||–||Diabetes Treatment Options
|-
| Endocrinology||[[Diabetes mellitus]]||Insulin Preparations||–||Insulin Preparations
|-
| Endocrinology||[[Diabetes mellitus]]||Complications||–||–
|-
| Endocrinology||[[Diabetes mellitus]]||Outpatient screening and treatment goals||–||–
|-
| Endocrinology||[[Diabetes mellitus]]||Management of hyperglycemia in inpatients||–||–
|-
| Endocrinology||[[Diabetic ketoacidosis]]||Precipitants||–||–
|-
| Endocrinology||[[Diabetic ketoacidosis]]||Pathophysiology||–||–
|-
| Endocrinology||[[Diabetic ketoacidosis]]||Clinical manifestations||–||–
|-
| Endocrinology||[[Diabetic ketoacidosis]]||Diagnostic studies||–||Typical DKA Flow Sheet Setup
|-
| Endocrinology||[[Diabetic ketoacidosis]]||Treatment||–||Treatment of DKA
|-
| Endocrinology||[[Hyperosmolar hyperglycemic state]]||Definition, precipitants, pathophysiology||–||–
|-
| Endocrinology||[[Hyperosmolar hyperglycemic state]]||Clinical manifestations & dx studies||–||–
|-
| Endocrinology||[[Hyperosmolar hyperglycemic state]]||Treatment||–||–
|-
| Endocrinology||[[Hypoglycemia]]||Clinical manifestations||–||–
|-
| Endocrinology||[[Hypoglycemia]]||Etiologies in diabetics||–||–
|-
| Endocrinology||[[Hypoglycemia]]||Etiologies in nondiabetics||–||–
|-
| Endocrinology||[[Hypoglycemia]]||Evaluation in nondiabetics||–||–
|-
| Endocrinology||[[Hypoglycemia]]||Treatment||–||–
|-
| Endocrinology||[[Lipid disorders]]||Measurements||–||–
|-
| Endocrinology||[[Lipid disorders]]||Primary dyslipidemia||–||–
|-
| Endocrinology||[[Lipid disorders]]||Secondary dyslipidemia||–||Secondary dyslipidemia
|-
| Endocrinology||[[Lipid disorders]]||Physical exam findings||–||–
|-
| Endocrinology||[[Lipid disorders]]||Treatment||–||NCEP Guidelines of Dyslipidemia
|-
| Endocrinology||[[Lipid disorders]]||Drug treatment||–||Drug Treatment of Dyslipidemia
|-
| Rheumatology||[[Arthritis]]||Approach to patients with joint pain||–||Key Physical Exam Findings in Joint Pain
|-
| Rheumatology||[[Arthritis]]||Approach to arthritis||Approach to arthritis||–
|-
| Rheumatology||[[Arthritis]]||Analysis of joint fluid||–||Analysis of Joint Fluid
|-
| Rheumatology||[[Arthritis]]||Comparison of major arthritides||–||Comparison of Major Arthritides
|-
| Rheumatology||[[Arthritis]]||Radiologic features||–||–
|-
| Rheumatology||[[Inflammatory markers & autoantibody testing]]||Inflammatory Markers||–||–
|-
| Rheumatology||[[Inflammatory markers & autoantibody testing]]||Autoantibody Testing||–||–
|-
| Rheumatology||[[Rheumatoid arthritis]]||Definition & epidemiology||–||–
|-
| Rheumatology||[[Rheumatoid arthritis]]||Clinical manifestations||–||Extra-Articular Manifestations of RA
|-
| Rheumatology||[[Rheumatoid arthritis]]||Laboratory & radiologic studies||–||–
|-
| Rheumatology||[[Rheumatoid arthritis]]||ACR/EULAR classification criteria of RA||–||ACR/EULAR classification criteria of RA
|-
| Rheumatology||[[Rheumatoid arthritis]]||Management||–||RA Therapeutics
|-
| Rheumatology||[[Adult onset still’s disease & relapsing polychondritis]]||Adult Onset Still’s Disease||–||–
|-
| Rheumatology||[[Adult onset still’s disease & relapsing polychondritis]]||Relapsing Polychondritis||–||–
|-
| Rheumatology||[[Gout]]||Definition & epidemiology||–||–
|-
| Rheumatology||[[Gout]]||Clinical manifestations||–||–
|-
| Rheumatology||[[Gout]]||Diagnostic studies||–||–
|-
| Rheumatology||[[Gout]]||Acute treatment||–||Acute Treatment of Gout
|-
| Rheumatology||[[Gout]]||Chronic treatment||–||Urate Lowering Therapy
|-
| Rheumatology||[[Calcium pyrophosphate dihydrate deposition disease]]||Definition||–||–
|-
| Rheumatology||[[Calcium pyrophosphate dihydrate deposition disease]]||Etiologies||–||–
|-
| Rheumatology||[[Calcium pyrophosphate dihydrate deposition disease]]||Clinical manifestations||–||–
|-
| Rheumatology||[[Calcium pyrophosphate dihydrate deposition disease]]||Diagnostic studies||–||–
|-
| Rheumatology||[[Calcium pyrophosphate dihydrate deposition disease]]||Treatment||–||–
|-
| Rheumatology||[[Seronegative spondyloarthritis]]||Classification system||–||–
|-
| Rheumatology||[[Seronegative spondyloarthritis]]||Epidemiology & pathogenesis||–||SpA Epidemiology and Features
|-
| Rheumatology||[[Seronegative spondyloarthritis]]||Major clinical manifestations||–||SpA Distinguishing Features
|-
| Rheumatology||[[Seronegative spondyloarthritis]]||Descriptions of skin manifestations||–||–
|-
| Rheumatology||[[Seronegative spondyloarthritis]]||Clinical assessment||–||–
|-
| Rheumatology||[[Seronegative spondyloarthritis]]||Treatment approach||–||–
|-
| Rheumatology||[[Infectious arthritis]]||Etiologies||–||–
|-
| Rheumatology||[[Infectious arthritis]]||Diagnosis||–||–
|-
| Rheumatology||[[Bacterial arthritis]]||Epidemiology & risk factors||–||–
|-
| Rheumatology||[[Bacterial arthritis]]||Clinical manifestations||–||–
|-
| Rheumatology||[[Bacterial arthritis]]||Additional diagnostic studies||–||–
|-
| Rheumatology||[[Bacterial arthritis]]||Treatment||–||Treatment of Bacterial Arthritis
|-
| Rheumatology||[[Bacterial arthritis]]||Prosthetic joint infections||–||–
|-
| Rheumatology||[[Disseminated gonococcal infection]]||Epidemiology||–||–
|-
| Rheumatology||[[Disseminated gonococcal infection]]||Clinical manifestations||–||–
|-
| Rheumatology||[[Disseminated gonococcal infection]]||Additional diagnostic studies||–||–
|-
| Rheumatology||[[Disseminated gonococcal infection]]||Treatment||–||–
|-
| Rheumatology||[[Olecranon and prepatellar bursitis]]||Epidemiology & risk factors||–||–
|-
| Rheumatology||[[Olecranon and prepatellar bursitis]]||Diagnosis||–||–
|-
| Rheumatology||[[Olecranon and prepatellar bursitis]]||Initial therapy||–||–
|-
| Rheumatology||[[Connective tissue diseases]]||Autoantibodies in Patients with Rheumatic Diseases||–||Autoantibodies in Patients with Rheumatic Diseases
|-
| Rheumatology||[[Systemic sclerosis and scleroderma]]||Definition & epidemiology||–||–
|-
| Rheumatology||[[Systemic sclerosis and scleroderma]]||Classification criteria||–||–
|-
| Rheumatology||[[Systemic sclerosis and scleroderma]]||Diagnostic studies & monitoring||–||Clinical Manifestations of Systemic Sclerosis
|-
| Rheumatology||[[Systemic sclerosis and scleroderma]]||Systemic Sclerosis Subgroup Comparison||–||SSc Subgroup Comparison
|-
| Rheumatology||[[Systemic sclerosis and scleroderma]]||Treatment||–||–
|-
| Rheumatology||[[Inflammatory myopathies]]||Definition & epidemiology||–||–
|-
| Rheumatology||[[Inflammatory myopathies]]||Clinical manifestations||–||–
|-
| Rheumatology||[[Inflammatory myopathies]]||Diagnostic studies||–||Differential Diagnosis of Myositides, Myopathies, and Myalgias
|-
| Rheumatology||[[Inflammatory myopathies]]||Treatment||–||–
|-
| Rheumatology||[[Sjogren's syndrome]]||Definition & epidemiology||–||–
|-
| Rheumatology||[[Sjogren's syndrome]]||Clinical manifestations||–||–
|-
| Rheumatology||[[Sjogren's syndrome]]||Diagnostic studies||–||–
|-
| Rheumatology||[[Sjogren's syndrome]]||Treatment||–||–
|-
| Rheumatology||[[Mixed connective tissue disease]]||Definition||–||–
|-
| Rheumatology||[[Mixed connective tissue disease]]||Clinical manifestations||–||–
|-
| Rheumatology||[[Mixed connective tissue disease]]||Diagnostic studies||–||–
|-
| Rheumatology||[[Mixed connective tissue disease]]||Treatment||–||–
|-
| Rheumatology||[[Raynaud's phenomenon]]||Clinical manifestations||–||–
|-
| Rheumatology||[[Raynaud's phenomenon]]||Primary Raynaud's phenomenon||–||–
|-
| Rheumatology||[[Raynaud's phenomenon]]||Secondary Raynaud's phenomenon||–||–
|-
| Rheumatology||[[Raynaud's phenomenon]]||Treatment||–||–
|-
| Rheumatology||[[Systemic lupus erythematosus]]||Epidemiology||–||Classification Criteria and Clinical Manifestations of SLE
|-
| Rheumatology||[[Systemic lupus erythematosus]]||Workup||–||Autoantibodies in SLE
|-
| Rheumatology||[[Systemic lupus erythematosus]]||Treatment||–||Treatment of SLE
|-
| Rheumatology||[[Systemic lupus erythematosus]]||Lupus nephritis||–||Lupus nephritis
|-
| Rheumatology||[[Systemic lupus erythematosus]]||Prognosis||–||–
|-
| Rheumatology||[[Systemic lupus erythematosus]]||Drug-induced lupus||–||–
|-
| Rheumatology||[[Vasculitis]]||Distinguishing Characteristics of Vasculitis Subtypes||–||Distinguishing Characteristics of Vasculitis Subtypes
|-
| Rheumatology||[[Large-vessel vasculitis]]||Takayasu's arteritis||–||–
|-
| Rheumatology||[[Large-vessel vasculitis]]||Giant cell arteritis||–||–
|-
| Rheumatology||[[Medium-vessel vasculitis]]||Polyarteritis nodosa||–||–
|-
| Rheumatology||[[Anca-associated small-vessel vasculitis]]||Differential Diagnosis of ANCA||–||Differential Diagnosis of ANCA
|-
| Rheumatology||[[Anca-associated small-vessel vasculitis]]||Granulomatosis with polyangiitis||–||–
|-
| Rheumatology||[[Anca-associated small-vessel vasculitis]]||Microscopic polyangiitis||–||–
|-
| Rheumatology||[[Anca-associated small-vessel vasculitis]]||Eosinophilic granulomatosis with polyangiitis||–||–
|-
| Rheumatology||[[Anca-associated small-vessel vasculitis]]||Renal-limited vasculitis||–||–
|-
| Rheumatology||[[Immune complex-associated small-vessel vasculitis]]||Henoch-Schonlein purpura||–||–
|-
| Rheumatology||[[Immune complex-associated small-vessel vasculitis]]||Cryoglobulinemic vasculitis||–||–
|-
| Rheumatology||[[Immune complex-associated small-vessel vasculitis]]||Connective tissue disease-associated vasculitis||–||–
|-
| Rheumatology||[[Immune complex-associated small-vessel vasculitis]]||Cutaneous leukocytoclastic angiitis||–||–
|-
| Rheumatology||[[Immune complex-associated small-vessel vasculitis]]||Behcet's syndrome||–||–
|-
| Rheumatology||[[Igg4-related disease]]||Definition & etiology||–||–
|-
| Rheumatology||[[Igg4-related disease]]||Clinical manifestations||–||–
|-
| Rheumatology||[[Igg4-related disease]]||Diagnosis||–||–
|-
| Rheumatology||[[Igg4-related disease]]||Treatment||–||–
|-
| Rheumatology||[[Cryoglobulinemia]]||Definition & types||–||–
|-
| Rheumatology||[[Cryoglobulinemia]]||Etiologies||–||–
|-
| Rheumatology||[[Cryoglobulinemia]]||Pathophysiology||–||–
|-
| Rheumatology||[[Cryoglobulinemia]]||Clinical manifestations||–||–
|-
| Rheumatology||[[Cryoglobulinemia]]||Diagnostic studies||–||–
|-
| Rheumatology||[[Cryoglobulinemia]]||Treatment||–||–
|-
| Rheumatology||[[Amyloidosis]]||Classification||–||Classification of Amyloidosis
|-
| Rheumatology||[[Amyloidosis]]||Clinical manifestations||–||Clinical Manifestations of Amyloidosis
|-
| Rheumatology||[[Amyloidosis]]||Diagnostic studies||–||–
|-
| Rheumatology||[[Amyloidosis]]||Treatment||–||–
|-
| Rheumatology||[[Amyloidosis]]||Prognosis||–||–
|-
| Neurology||[[Change in mental status]]||Definitions||–||–
|-
| Neurology||[[Change in mental status]]||Initial evaluation||–||Etiologies of Altered Mental Status
|-
| Neurology||[[Change in mental status]]||Neuro Exam of Altered Mental Status||–||Neuro Exam of Altered Mental Status
|-
| Neurology||[[Change in mental status]]||Glasgow Coma Scale||–||Glasgow Coma Scale
|-
| Neurology||[[Change in mental status]]||Initial treatment||–||–
|-
| Neurology||[[Change in mental status]]||Diagnostic studies||–||–
|-
| Neurology||[[Change in mental status]]||Further treatment of delirium||–||–
|-
| Neurology||[[Anoxic brain injury]]||Prevalence||–||–
|-
| Neurology||[[Anoxic brain injury]]||Initial evaluation||–||–
|-
| Neurology||[[Anoxic brain injury]]||Induced hypothermia||–||–
|-
| Neurology||[[Anoxic brain injury]]||Ongoing evaluation||–||–
|-
| Neurology||[[Anoxic brain injury]]||Prognosis||–||–
|-
| Neurology||[[Seizures]]||Definitions||–||–
|-
| Neurology||[[Seizures]]||Differential diagnosis||–||Seizure vs Syncope
|-
| Neurology||[[Seizures]]||Etiologies||–||–
|-
| Neurology||[[Seizures]]||Clinical manifestations||–||–
|-
| Neurology||[[Seizures]]||Clinical evaluation||–||–
|-
| Neurology||[[Seizures]]||Diagnostic studies||–||–
|-
| Neurology||[[Seizures]]||Treatment||–||Antiepileptic Drugs and Side Effects
|-
| Neurology||[[Seizures]]||Status epilepticus||–||Treatment of Status Epilepticus
|-
| Neurology||[[Alcohol withdrawal]]||Pathophysiology||–||–
|-
| Neurology||[[Alcohol withdrawal]]||Clinical manifestations||–||–
|-
| Neurology||[[Alcohol withdrawal]]||Clinical Institute Withdrawal Assessment scale for Alcohol||–||CIWA-Ar Scale
|-
| Neurology||[[Alcohol withdrawal]]||Treatment||–||–
|-
| Neurology||[[Ischemic stroke]]||Etiologies||–||–
|-
| Neurology||[[Ischemic stroke]]||Clinical manifestations||–||Stroke Syndromes by Vascular Territory
|-
| Neurology||[[Ischemic stroke]]||Transient ischemic attack||–||–
|-
| Neurology||[[Ischemic stroke]]||Physical exam||–||–
|-
| Neurology||[[Ischemic stroke]]||Acute workup||–||–
|-
| Neurology||[[Ischemic stroke]]||Workup to assess for etiology/modifiable risk factors||–||–
|-
| Neurology||[[Ischemic stroke]]||Acute treatment of ischemic stroke||–||–
|-
| Neurology||[[Ischemic stroke]]||Secondary stroke prevention||–||–
|-
| Neurology||[[Ischemic stroke]]||Patent foramen ovale||–||–
|-
| Neurology||[[Intracranial hemorrhage]]||Classification by location||–||–
|-
| Neurology||[[Intracranial hemorrhage]]||Etiologies||–||–
|-
| Neurology||[[Intracranial hemorrhage]]||Clinical manifestations||–||–
|-
| Neurology||[[Intracranial hemorrhage]]||Workup||–||–
|-
| Neurology||[[Intracranial hemorrhage]]||Management||–||–
|-
| Neurology||[[Weakness & neuromuscular dysfunction]]||Weakness & Neuromuscular Dysfunction||–||Weakness & Neuromuscular Dysfunction
|-
| Neurology||[[Peripheral neuropathies]]||Etiologies||–||–
|-
| Neurology||[[Peripheral neuropathies]]||Clinical manifestations||–||–
|-
| Neurology||[[Peripheral neuropathies]]||Diagnostic studies||–||–
|-
| Neurology||[[Peripheral neuropathies]]||Treatment of neuropathic pain||–||–
|-
| Neurology||[[Guillain-barre syndrome]]||Definition & epidemiology||–||–
|-
| Neurology||[[Guillain-barre syndrome]]||Clinical manifestations||–||–
|-
| Neurology||[[Guillain-barre syndrome]]||Diagnostic studies||–||–
|-
| Neurology||[[Guillain-barre syndrome]]||Treatment||–||–
|-
| Neurology||[[Myasthenia gravis]]||Definition & epidemiology||–||–
|-
| Neurology||[[Myasthenia gravis]]||Clinical manifestations||–||–
|-
| Neurology||[[Myasthenia gravis]]||Diagnostic studies||–||–
|-
| Neurology||[[Myasthenia gravis]]||Treatment||–||–
|-
| Neurology||[[Myopathies]]||Definition & epidemiology||–||–
|-
| Neurology||[[Myopathies]]||Clinical manifestations||–||–
|-
| Neurology||[[Myopathies]]||Diagnostic studies||–||–
|-
| Neurology||[[Headache]]||Primary headache syndromes||–||–
|-
| Neurology||[[Headache]]||Secondary causes of headache||–||–
|-
| Neurology||[[Headache]]||Clinical evaluation||–||–
|-
| Neurology||[[Migraine]]||Epidemiology||–||–
|-
| Neurology||[[Migraine]]||Definition & clinical manifestations||–||–
|-
| Neurology||[[Migraine]]||Treatment||–||–
|-
| Neurology||[[Back and spinal cord disease]]||Differential diagnosis of back pain||–||–
|-
| Neurology||[[Back and spinal cord disease]]||Initial evaluation||–||–
|-
| Neurology||[[Spinal cord compression]]||Clinical manifestations||–||–
|-
| Neurology||[[Spinal cord compression]]||Evaluation & treatment||–||Conus Medullaris vs Cauda Equina Syndromes
|-
| Neurology||[[Nerve root compression]]||Clinical manifestations||–||Cervical and Lumbar Radiculopathy
|-
| Neurology||[[Nerve root compression]]||Neurogenic vs Vascular Claudication||–||Neurogenic vs Vascular Claudication
|-
| Neurology||[[Nerve root compression]]||Treatment of nerve root compression||–||–
|-
| Surgical Issues||[[Abdominal pain]]||Viscera and Area to which pain referred||–||Viscera and Area to which pain referred
|-
| Surgical Issues||[[Abdominal pain]]||Etiologies of Abdominal Pain by Location||Etiologies of Abdominal Pain by Location||–
|-
| Surgical Issues||[[Abdominal pain]]||Inital evaluation||–||–
|-
| Surgical Issues||[[Acute abdomen]]||Definition||–||–
|-
| Surgical Issues||[[Acute abdomen]]||Etiologies||–||–
|-
| Surgical Issues||[[Acute abdomen]]||Inital evaluation||–||–
|-
| Surgical Issues||[[Acute abdomen]]||Initial management||–||–
|-
| Surgical Issues||[[Extremity emergencies]]||Acute limb ischemia||–||–
|-
| Surgical Issues||[[Extremity emergencies]]||Compartment syndrome||–||–
|-
| Surgical Issues||[[Surgical tubes, drains, and wounds]]||Tracheostomy||–||–
|-
| Surgical Issues||[[Surgical tubes, drains, and wounds]]||Chest tubes||–||–
|-
| Surgical Issues||[[Surgical tubes, drains, and wounds]]||Gastrostomy/jejunostomy tubes||–||–
|-
| Surgical Issues||[[Surgical tubes, drains, and wounds]]||Suture/staple removal||–||–
|-
| Ob/Gyn Issues||[[Vaginal bleeding]]||Etiologies||–||–
|-
| Ob/Gyn Issues||[[Vaginal bleeding]]||History & exam||–||–
|-
| Ob/Gyn Issues||[[Vaginal bleeding]]||Laboratory evaluation & imaging||–||–
|-
| Ob/Gyn Issues||[[Vaginal discharge]]||Etiologies||–||–
|-
| Ob/Gyn Issues||[[Vaginal discharge]]||Initial evaluation||–||–
|-
| Ob/Gyn Issues||[[Vaginal discharge]]||Treatment||–||–
|-
| Ob/Gyn Issues||[[Adnexal mass in non-pregnant woman]]||Etiologies||–||–
|-
| Ob/Gyn Issues||[[Adnexal mass in non-pregnant woman]]||Initial evaluation||–||–
|-
| Ophthalmic Issues||[[Acute visual changes]]||Etiologies of Acute Vision Loss||–||Etiologies of Acute Vision Loss
|-
| Ophthalmic Issues||[[Acute visual changes]]||Descriptions & etiologies of other visual changes||–||–
|-
| Ophthalmic Issues||[[Red eye]]||Common Etiologies of Red Eye||–||Common Etiologies of Red Eye
|-
| Ophthalmic Issues||[[Other conditions]]||Optic Nerve Disorders||–||–
|-
| Ophthalmic Issues||[[Other conditions]]||Ocular motor palsies||–||–
|-
| Ophthalmic Issues||[[Initial evaluation]]||Initial evaluation||–||–
|-
| ICU Medications||[[Icu medications]]||ICU Medications||–||ICU Medications
|-
| ACLS||[[Pulmonary edema, hypotension or shock]]||ACLS pulmonary edema, hypotension or shock algorithm||ACLS pulmonary edema, hypotension or shock algorithm||–
|-
| ACLS||[[Tachycardia]]||ACLS tachycardia algorithm||ACLS tachycardia algorithm||–
|-
| ACLS||[[Bradycardia]]||ACLS bradycardia algorithm||ACLS bradycardia algorithm||–
|-
| ACLS||[[Vf/pulseless vt, asystole, & pea]]||ACLS VF/Pulseless VT, asystole, & PEA algorithm||ACLS VF/Pulseless VT, asystole, & PEA algorithm||–
|-
| Quick References||[[Chest imaging patterns]]||Chest Imaging Patterns||–||Chest Imaging Patterns
|-
| Quick References||[[Peripheral smear findings]]||Peripheral Smear Findings||–||Peripheral Smear Findings
|-
| Quick References||[[Heparin for thromboembolism]]||Heparin for Thromboembolism||–||Heparin for Thromboembolism
|-
| Quick References||[[Heparin for acs]]||Heparin for ACS||–||Heparin for ACS
|-
| Quick References||[[Warfarin loading nomogram]]||Warfarin Loading Nomogram||–||Warfarin Loading Nomogram
|-
| Quick References||[[Warfarin-heparin overlap therapy]]||Warfarin-Heparin Overlap Therapy||–||Common Warfarin-Drug Interactions
|}

Latest revision as of 14:51, 10 November 2016


Specialty Topic Section Figure Table
Cardiology Electrocardiography Approach QRS axis –
Cardiology Electrocardiography Left axis deviation (LAD) – –
Cardiology Electrocardiography Right axis deviation (RAD) – Bunble branch blocks
Cardiology Electrocardiography Prolonged QT interval ECG P Wave Criteria –
Cardiology Electrocardiography Left ventricular hypertrophy (LVH) – –
Cardiology Electrocardiography Right ventricular hypertrophy (RVH) – –
Cardiology Electrocardiography Ddx of dominant R wave in V1 or V2 – –
Cardiology Electrocardiography Poor R wave progression (PRWP) – –
Cardiology Electrocardiography Pathologic Q waves – –
Cardiology Electrocardiography ST elevation (STE) – –
Cardiology Electrocardiography ST depression (STD) – –
Cardiology Electrocardiography T wave inversion (TWI) – –
Cardiology Electrocardiography Low voltage – –
Cardiology Chest pain Causes of Chest Pain – Causes of Chest Pain
Cardiology Chest pain Initial approach – –
Cardiology Noninvasive evaluation of cad Noninvasive Evaluation of CAD – Noninvasive Evaluation of CAD
Cardiology Noninvasive evaluation of cad Stress testing – –
Cardiology Noninvasive evaluation of cad Test results – –
Cardiology Noninvasive evaluation of cad High-risk test results – –
Cardiology Noninvasive evaluation of cad Myocardial viability – –
Cardiology Noninvasive evaluation of cad CT & MR coronary angio – –
Cardiology Noninvasive evaluation of cad Coronary artery calcium score – –
Cardiology Coronary angiography and revascularization Indications for coronary angiography in stable CAD or asx Pts – –
Cardiology Coronary angiography and revascularization Precath checklist – –
Cardiology Coronary angiography and revascularization Coronary revascularization in stable CAD – –
Cardiology Coronary angiography and revascularization PCI – –
Cardiology Coronary angiography and revascularization Post-PCI complications – –
Cardiology Acute coronary syndromes Ddx (causes of myocardial ischemia/infarction other than atherosclerotic plaque rupture) – Spectrum of Acute Coronary Syndromes
Cardiology Acute coronary syndromes Clinical manifestations – –
Cardiology Acute coronary syndromes Physical exam – –
Cardiology Acute coronary syndromes Diagnostic studies – Localization of MI
Cardiology Acute coronary syndromes Prinzmetal’s (variant) angina – –
Cardiology Acute coronary syndromes Approach to triage – Likelihood of ACS
Cardiology Acute coronary syndromes Coronary angiography – –
Cardiology Ua/nstemi Approach to UA/NSTEMI Approach to UA/NSTEMI –
Cardiology Ua/nstemi TIMI Risk Score for UA/NSTEMI – TIMI Risk Score for UA/NSTEMI
Cardiology Ua/nstemi Anti-Ischemic and Antiplatelet Therapy for UA/NSTEMI – Anti-Ischemic and Antiplatelet Therapy for UA/NSTEMI
Cardiology Ua/nstemi Anticoagulant Therapy for UA/NSTEMI – Anticoagulant Therapy for UA/NSTEMI
Cardiology Stemi Requisite STE (at J point) – –
Cardiology Stemi Reperfusion (“time is muscle”) – Fibrinolysis vs Hospital Transfer for Primary PCI
Cardiology Stemi Primary PCI – –
Cardiology Stemi Fibrinolysis – Contraindications to Fibrinolysis
Cardiology Stemi Non-primary PCI – –
Cardiology Stemi Antiplatelet Therapy for STEMI – Antiplatelet Therapy for STEMI
Cardiology Stemi Anticoagulant Therapy for STEMI – Anticoagulant Therapy for STEMI
Cardiology Stemi Immediate Adjunctive Therapy for STEMI – Immediate Adjunctive Therapy for STEMI
Cardiology Stemi LV failure – –
Cardiology Stemi Inferior MI complications – –
Cardiology Stemi Mechanical complications – –
Cardiology Stemi Post-MI Arrhythmias – Other Post-MI Complications
Cardiology Stemi Prognosis based on Killip Class – Prognosis based on Killip Class
Cardiology Stemi Prognosis based on Forrester Class – Prognosis based on Forrester Class
Cardiology Pre-discharge checklist and long-term post-acs management Risk stratification – –
Cardiology Pre-discharge checklist and long-term post-acs management Medications (barring contraindications) – –
Cardiology Pre-discharge checklist and long-term post-acs management ICD – –
Cardiology Pre-discharge checklist and long-term post-acs management Risk factors and lifestyle modifications – –
Cardiology Pa catheter and tailored therapy Rationale PA Catheter Waveforms –
Cardiology Pa catheter and tailored therapy Indications – –
Cardiology Pa catheter and tailored therapy Efficacy concerns – –
Cardiology Pa catheter and tailored therapy Placement – –
Cardiology Pa catheter and tailored therapy Complications – –
Cardiology Pa catheter and tailored therapy Intracardiac pressures – –
Cardiology Pa catheter and tailored therapy Cardiac output – –
Cardiology Pa catheter and tailored therapy Tailored therapy in cardiogenic shock – Hemodynamic Profiles of Various Forms of Shock
Cardiology Heart failure Definitions – –
Cardiology Heart failure History – –
Cardiology Heart failure Functional classification (New York Heart Association class) – –
Cardiology Heart failure Physical exam (“2-minute” hemodynamic profile) – –
Cardiology Heart failure Evaluation for the presence of heart failure – –
Cardiology Heart failure Evaluation of the causes of heart failure Approach to left-sided heart failure –
Cardiology Heart failure Precipitants of acute heart failure – –
Cardiology Heart failure Treatment of acute decompensated heart failure – Treatment of acute decompensated heart failure
Cardiology Heart failure Treatment of advanced heart failure – Recommended Chronic Therapy by HF Stage
Cardiology Heart failure Heart failure with reduced EF (HFrEF) – Treatment of HFrEF
Cardiology Heart failure Heart failure with preserved EF (HFpEF) – –
Cardiology Dilated cardiomyopathy Definition and epidemiology – –
Cardiology Dilated cardiomyopathy Etiologies – –
Cardiology Dilated cardiomyopathy Clinical manifestations – –
Cardiology Dilated cardiomyopathy Diagnostic studies and workup – –
Cardiology Dilated cardiomyopathy Treatment – –
Cardiology Hypertrophic cardiomyopathy Definition and epidemiology – –
Cardiology Hypertrophic cardiomyopathy Pathology – –
Cardiology Hypertrophic cardiomyopathy Pathophysiology – –
Cardiology Hypertrophic cardiomyopathy Clinical manifestations – –
Cardiology Hypertrophic cardiomyopathy Physical exam – –
Cardiology Hypertrophic cardiomyopathy Diagnostic studies – –
Cardiology Hypertrophic cardiomyopathy Treatment – –
Cardiology Restrictive cardiomyopathy Definition – –
Cardiology Restrictive cardiomyopathy Etiology – –
Cardiology Restrictive cardiomyopathy Pathology & pathophysiology – –
Cardiology Restrictive cardiomyopathy Clinical manifestations – –
Cardiology Restrictive cardiomyopathy Physical exam – –
Cardiology Restrictive cardiomyopathy Diagnostic studies – –
Cardiology Restrictive cardiomyopathy Treatment – –
Cardiology Aortic stenosis Etiology – –
Cardiology Aortic stenosis Clinical manifestations – –
Cardiology Aortic stenosis Physical exam Hemodynamics of Aortic Stenosis –
Cardiology Aortic stenosis Diagnostic studies – Classification of Aortic Stenosis
Cardiology Aortic stenosis Treatment – –
Cardiology Aortic insufficiency Etiology – –
Cardiology Aortic insufficiency Clinical manifestations – Classic Eponymous Signs in Chronic Aortic Insufficiency
Cardiology Aortic insufficiency Physical exam Hemodynamics of Aortic Insufficiency –
Cardiology Aortic insufficiency Diagnostic studies – –
Cardiology Aortic insufficiency Treatment – –
Cardiology Mitral regurgitation Etiology – –
Cardiology Mitral regurgitation Clinical manifestations – –
Cardiology Mitral regurgitation Physical exam Hemodynamics of Mitral Regurgitation –
Cardiology Mitral regurgitation Diagnostic studies – Classification of Mitral Regurgitation
Cardiology Mitral regurgitation Treatment – –
Cardiology Mitral stenosis Etiology – –
Cardiology Mitral stenosis Clinical manifestations – –
Cardiology Mitral stenosis Physical exam Hemodynamics of Mitral Stenosis –
Cardiology Mitral stenosis Diagnostic studies – Classification of Mitral Stenosis
Cardiology Mitral stenosis Treatment – –
Cardiology Mitral valve prolapse Definition and etiology – –
Cardiology Mitral valve prolapse Clinical manifestations – –
Cardiology Mitral valve prolapse Physical exam – –
Cardiology Mitral valve prolapse Treatment – –
Cardiology Tricuspid regurgitation Tricuspid regurgitation – –
Cardiology Prosthetic heart valves Mechanical Superior View of Heart Valves –
Cardiology Prosthetic heart valves Bioprosthetic – –
Cardiology Prosthetic heart valves Physical exam – –
Cardiology Prosthetic heart valves Anticoagulation & antiplatelet therapy – Periprocedural Bridging of Anticoagulation in Pts with MV
Cardiology Prosthetic heart valves Correction of overanticoagulation – –
Cardiology Prosthetic heart valves Endocarditis prophylaxis – –
Cardiology Prosthetic heart valves Complications – –
Cardiology Pericardial disease Anatomy – –
Cardiology Pericardial disease Disease states – –
Cardiology Pericarditis and pericardial effusion Etiology – Etiologies of Acute Pericarditis
Cardiology Pericarditis and pericardial effusion Clinical manifestations – –
Cardiology Pericarditis and pericardial effusion Physical exam – –
Cardiology Pericarditis and pericardial effusion Diagnostic studies – –
Cardiology Pericarditis and pericardial effusion Workup for effusion – –
Cardiology Pericarditis and pericardial effusion Treatment of pericarditis – –
Cardiology Pericardial tamponade Etiology – –
Cardiology Pericardial tamponade Pathophysiology – –
Cardiology Pericardial tamponade Clinical manifestations – –
Cardiology Pericardial tamponade Physical exam – –
Cardiology Pericardial tamponade Diagnostic studies – –
Cardiology Pericardial tamponade Treatment – –
Cardiology Constrictive pericarditis Etiology – Constrictive Pericarditis vs Restrictive Cardiomyopathy
Cardiology Constrictive pericarditis Pathophysiology – –
Cardiology Constrictive pericarditis Clinical manifestations – –
Cardiology Constrictive pericarditis Physical exam – –
Cardiology Constrictive pericarditis Diagnostic studies – –
Cardiology Constrictive pericarditis Treatment – –
Cardiology Hypertension Classification – JNC VII Classification of Hypertension
Cardiology Hypertension Epidemiology – –
Cardiology Hypertension Etiologies – Secondary Causes of Hypertension
Cardiology Hypertension Standard workup – –
Cardiology Hypertension Complications of HTN – –
Cardiology Hypertension Treatment – –
Cardiology Hypertensive crises Definitions – –
Cardiology Hypertensive crises Precipitants – –
Cardiology Hypertensive crises Treatment – Drugs for Hypertensive Crises
Cardiology Aortic aneurysms Definitions – –
Cardiology Aortic aneurysms Epidemiology – –
Cardiology Aortic aneurysms Pathophysiology – –
Cardiology Aortic aneurysms Screening – –
Cardiology Aortic aneurysms Diagnostic studies – –
Cardiology Aortic aneurysms Treatment – –
Cardiology Acute aortic syndromes Definitions – –
Cardiology Acute aortic syndromes Classification – –
Cardiology Acute aortic syndromes Risk factors – –
Cardiology Acute aortic syndromes Clinical manifestations – Clinical Manifestations and Physical Exam of Acute Aortic Syndromes
Cardiology Acute aortic syndromes Diagnostic studies – –
Cardiology Acute aortic syndromes Treatment – –
Cardiology Acute aortic syndromes Complications – –
Cardiology Bradycardias, av block, and av dissociation Sinus bradycardia (SB) – –
Cardiology Bradycardias, av block, and av dissociation Sick sinus syndrome (SSS) – –
Cardiology Bradycardias, av block, and av dissociation AV Block – Classification of AV Block
Cardiology Bradycardias, av block, and av dissociation AV Dissociation – –
Cardiology Bradycardias, av block, and av dissociation Temporary pacing wires – –
Cardiology Supraventricular tachycardias Approach – Approach to SVT
Cardiology Supraventricular tachycardias Etiology – Common Etiologies of SVT
Cardiology Supraventricular tachycardias Diagnosis – Diagnosis of SVT
Cardiology Supraventricular tachycardias Treatment – Treatment of SVT
Cardiology Accessory pathways (wolff-parkinson-white) Definitions Delta wave of WPW Syndrome –
Cardiology Accessory pathways (wolff-parkinson-white) Classic tachycardias of WPW – –
Cardiology Accessory pathways (wolff-parkinson-white) Treatment – –
Cardiology Wide-complex tachycardias Etiology – –
Cardiology Wide-complex tachycardias Monomorphic ventricular tachycardia (MMVT) Epsilon wave in ARVD –
Cardiology Wide-complex tachycardias Polymorphic ventricular tachycardia (PMVT) ECG of Brugada Syndrome –
Cardiology Wide-complex tachycardias Diagnostic clues that favor VT (assume until proven o/w) – –
Cardiology Wide-complex tachycardias Long-term management – –
Cardiology Atrial fibrillation Classification – –
Cardiology Atrial fibrillation Epidemiology and etiologies – –
Cardiology Atrial fibrillation Evaluation – Approach to Acute AF
Cardiology Atrial fibrillation Strategies for recurrent AF – Rate Control for AF
Cardiology Atrial fibrillation Cardioversion – Antiarrhythmic Drugs for AF
Cardiology Atrial fibrillation Nonpharmacologic therapy – –
Cardiology Atrial fibrillation Oral anticoagulation – Novel Oral Anticoagulants for Nonvalvular AF
Cardiology Syncope Definition – –
Cardiology Syncope Etiologies – –
Cardiology Syncope Workup Approach to Syncope –
Cardiology Syncope Other diagnostic studies – –
Cardiology Syncope High-risk features – –
Cardiology Syncope Treatment – –
Cardiology Syncope Prognosis – –
Cardiology Intracardiac devices Pacemaker Code – Pacemaker Code
Cardiology Intracardiac devices Common Pacing Modes – Common Pacing Modes
Cardiology Intracardiac devices Indications for Permanent Pacing – Indications for Permanent Pacing
Cardiology Intracardiac devices Permanent Pacemaker Complications – Permanent Pacemaker Complications
Cardiology Intracardiac devices Cardiac resynch therapy (CRT)/Biventricular (BiV) pacing – –
Cardiology Intracardiac devices Implantable cardiac defibrillator (ICD) – –
Cardiology Intracardiac devices Device infection – –
Cardiology Cardiac risk assessment for noncardiac surgery Clinical Assessment – Clinical Assessment
Cardiology Cardiac risk assessment for noncardiac surgery Surgery-Specific Risk – Surgery-Specific Risk
Cardiology Cardiac risk assessment for noncardiac surgery Functional Capacity – Functional Capacity
Cardiology Cardiac risk assessment for noncardiac surgery Noninvasive Testing Result – Noninvasive Testing Result
Cardiology Cardiac risk assessment for noncardiac surgery Preoperative evaluation ACC/AHA approach to preoperative cardiovascular evaluation for noncardiac surgery –
Cardiology Cardiac risk assessment for noncardiac surgery Preoperative testing and assessment – –
Cardiology Cardiac risk assessment for noncardiac surgery Pre- & perioperative management – –
Cardiology Cardiac risk assessment for noncardiac surgery Perioperative β-blocker – –
Cardiology Cardiac risk assessment for noncardiac surgery Postoperative monitoring – –
Cardiology Peripheral artery disease Clinical features – –
Cardiology Peripheral artery disease Diagnosis – –
Cardiology Peripheral artery disease Treatment – –
Cardiology Peripheral artery disease Acute limb ischemia (ALI) – –
Pulmonary Dyspnea Etiologies – Etiologies of Dyspnea
Pulmonary Dyspnea Evaluation – –
Pulmonary Pulmonary function tests Approach to abnormal PFTs Approach to abnormal PFTs –
Pulmonary Asthma Definition and epidemiology – –
Pulmonary Asthma Clinical manifestations – –
Pulmonary Asthma Physical examination – –
Pulmonary Asthma Diagnostic studies – –
Pulmonary Asthma Ddx – –
Pulmonary Asthma “Asthma plus” syndromes – –
Pulmonary Asthma “Reliever” medications – –
Pulmonary Asthma “Controller” meds – –
Pulmonary Asthma Other – –
Pulmonary Asthma Principles of treatment – Asthma Stepwise Therapy
Pulmonary Asthma exacerbation Evaluation – Severity of Asthma Exacerbation
Pulmonary Asthma exacerbation Initial treatment Disposition of patients after initial treatment of asthma exacerbation –
Pulmonary Asthma exacerbation ICU-level care – –
Pulmonary Anaphylaxis Definition and pathophysiology – –
Pulmonary Anaphylaxis Diagnosis – –
Pulmonary Anaphylaxis Treatment – –
Pulmonary Anaphylaxis Disposition – –
Pulmonary Chronic obstructive pulmonary disease Definition and epidemiology – Emphysema vs Chronic Bronchitis
Pulmonary Chronic obstructive pulmonary disease Pathogenesis – –
Pulmonary Chronic obstructive pulmonary disease Clinical manifestations – –
Pulmonary Chronic obstructive pulmonary disease Diagnostic studies – –
Pulmonary Chronic obstructive pulmonary disease Chronic treatment – –
Pulmonary Chronic obstructive pulmonary disease Staging and prognosis – COPD Staging and Recommended Therapies by GOLD Criteria
Pulmonary Chronic obstructive pulmonary disease Exacerbation – COPD Exacerbation Treatment
Pulmonary Hemoptysis Definition and pathophysiology – –
Pulmonary Hemoptysis Etiologies – Etiologies of Hemoptysis
Pulmonary Hemoptysis Diagnostic workup – –
Pulmonary Hemoptysis Treatment – –
Pulmonary Bronchiectasis Definition and epidemiology – –
Pulmonary Bronchiectasis Initial workup – Etiologies of Bronchiectasis
Pulmonary Bronchiectasis Treatment – –
Pulmonary Solitary pulmonary nodule Principles – Etiologies of SPN
Pulmonary Solitary pulmonary nodule Initial evaluation – –
Pulmonary Solitary pulmonary nodule Diagnostic studies – –
Pulmonary Solitary pulmonary nodule Management – –
Pulmonary Obstructive sleep apnea Definition and pathophysiology – –
Pulmonary Obstructive sleep apnea Clinical manifestations – –
Pulmonary Obstructive sleep apnea Diagnosis and treatment – –
Pulmonary Interstitial lung disease Workup of ILD – –
Pulmonary Interstitial lung disease Etiologies of ILD – Clinical Manifestations of Sarcoidosis
Pulmonary Interstitial lung disease Idiopathic Interstitial Pneumonias – Classification of Idiopathic Interstitial Pneumonia
Pulmonary Pleural effusion Pathophysiology – –
Pulmonary Pleural effusion Transudates – –
Pulmonary Pleural effusion Exudates – –
Pulmonary Pleural effusion Diagnostic studies – Characteristics of Pleural Fluid
Pulmonary Pleural effusion Treatment – –
Pulmonary Venous thromboembolism Definitions – –
Pulmonary Venous thromboembolism Risk factors – Thromboprophylaxis
Pulmonary Venous thromboembolism Clinical manifestations—DVT – Simplified Wells Pretest Probability Scoring for DVT
Pulmonary Venous thromboembolism Diagnostic studies—DVT Approach to Suspected DVT –
Pulmonary Venous thromboembolism Clinical manifestations—PE – Simplified Wells Pretest Probability Scoring for PE
Pulmonary Venous thromboembolism Diagnostic studies—PE Approach to Suspected PE using CTA –
Pulmonary Venous thromboembolism Workup for idiopathic VTE – –
Pulmonary Venous thromboembolism Risk stratification for Pts with PE – –
Pulmonary Venous thromboembolism Treatment of VTE – –
Pulmonary Venous thromboembolism Complications & prognosis – –
Pulmonary Pulmonary hypertension Pathobiology – Etiologies of Pulmonary Hypertension
Pulmonary Pulmonary hypertension Clinical manifestations – –
Pulmonary Pulmonary hypertension Physical exam – –
Pulmonary Pulmonary hypertension Diagnostic studies & workup – –
Pulmonary Pulmonary hypertension Treatment Treatment of PAH –
Pulmonary Pulmonary hypertension Treatment – Vasoactive Agents for PAH
Pulmonary Pulmonary hypertension Management of ICU patient – –
Pulmonary Pulmonary hypertension Prognosis – –
Pulmonary Respiratory failure Hypoxia Workup of acute hypoxemia –
Pulmonary Respiratory failure Chemical Causes of Cellular Hypoxia – Chemical Causes of Cellular Hypoxia
Pulmonary Respiratory failure Hypercapnia – Etiologies of Hypercapnia
Pulmonary Mechanical ventilation Indications – –
Pulmonary Mechanical ventilation Choosing settings – –
Pulmonary Mechanical ventilation Pick Ventilator Mode – Pick Ventilator Mode
Pulmonary Mechanical ventilation Choose Volume Targeted or Pressure Targeted – Choose Volume Targeted or Pressure Targeted
Pulmonary Mechanical ventilation Set Remaining Variables – Set Remaining Variables
Pulmonary Mechanical ventilation Initial Settings – Initial Settings
Pulmonary Mechanical ventilation Noninvasive CPAP/Ventilation – Noninvasive CPAP/Ventilation
Pulmonary Mechanical ventilation Tailoring the ventilator settings – –
Pulmonary Mechanical ventilation Acute ventilatory deterioration Approach to acute ventilatory deterioration –
Pulmonary Mechanical ventilation Weaning from the ventilator – –
Pulmonary Mechanical ventilation Complications – –
Pulmonary Acute respiratory distress syndrome New “Berlin” definition – –
Pulmonary Acute respiratory distress syndrome Pathophysiology – Etiologies of ARDS
Pulmonary Acute respiratory distress syndrome Treatment – Ventilator Strategies by VILI Mechanisms
Pulmonary Acute respiratory distress syndrome Prognosis – –
Pulmonary Sepsis Definitions – Sepsis Definitions
Pulmonary Sepsis Fluids & vasoactive drugs – –
Pulmonary Sepsis Antibiotics – –
Pulmonary Sepsis Steroids – –
Pulmonary Sepsis Activated protein C – –
Pulmonary Sepsis Intensive glycemic control – –
Gastroenterology Dysphagia Definitions Etiologies of and approach to dysphagia –
Gastroenterology Achalasia Achalasia – –
Gastroenterology Other esophageal disorders Other esophageal disorders – –
Gastroenterology Gastroesophageal reflux disease Pathophysiology – –
Gastroenterology Gastroesophageal reflux disease Clinical manifestations – –
Gastroenterology Gastroesophageal reflux disease Diagnosis – –
Gastroenterology Gastroesophageal reflux disease Treatment – –
Gastroenterology Gastroesophageal reflux disease Complications – –
Gastroenterology Dyspepsia Definition – –
Gastroenterology Dyspepsia Etiologies – –
Gastroenterology Dyspepsia Treatment of functional dyspepsia – –
Gastroenterology Peptic ulcer disease Epidemiology & etiologies – –
Gastroenterology Peptic ulcer disease Clinical manifestations – –
Gastroenterology Peptic ulcer disease Diagnostic studies – –
Gastroenterology Peptic ulcer disease Treatment – –
Gastroenterology Peptic ulcer disease Prophylaxis if ASA/NSAID required – –
Gastroenterology Gastrointestinal bleeding Definition – –
Gastroenterology Gastrointestinal bleeding Etiologies of upper GI bleed (UGIB) – –
Gastroenterology Gastrointestinal bleeding Etiologies of lower GI bleed (LGIB) – –
Gastroenterology Gastrointestinal bleeding Clinical manifestations – –
Gastroenterology Gastrointestinal bleeding Initial management – –
Gastroenterology Gastrointestinal bleeding Workup – –
Gastroenterology Gastrointestinal bleeding Diagnostic studies – –
Gastroenterology Gastrointestinal bleeding Treatment of GIB by Etiologies – Treatment of GIB by Etiologies
Gastroenterology Gastrointestinal bleeding Obscure GIB – –
Gastroenterology Acute diarrhea Infectious Etiologies of Acute Diarrhea – Infectious Etiologies of Acute Diarrhea
Gastroenterology Acute diarrhea Evaluation – –
Gastroenterology Acute diarrhea Treatment – –
Gastroenterology Clostridium difficile-associated diarrhea Pathogenesis – –
Gastroenterology Clostridium difficile-associated diarrhea Clinical manifestations – –
Gastroenterology Clostridium difficile-associated diarrhea Diagnosis – –
Gastroenterology Clostridium difficile-associated diarrhea Treatment – –
Gastroenterology Chronic diarrhea Medications – –
Gastroenterology Chronic diarrhea Osmotic – –
Gastroenterology Chronic diarrhea Malabsorption – –
Gastroenterology Chronic diarrhea Inflammatory – –
Gastroenterology Chronic diarrhea Secretory – –
Gastroenterology Chronic diarrhea Motility – –
Gastroenterology Chronic diarrhea Workup of chronic diarrhea Workup of chronic diarrhea –
Gastroenterology Constipation and adynamic ileus Constipation – –
Gastroenterology Constipation and adynamic ileus Acute pseudo-obstruction (adynamic ileus) – –
Gastroenterology Nutrition in hospitalized patients Pathophysiology – –
Gastroenterology Nutrition in hospitalized patients Critical illness – –
Gastroenterology Nutrition in hospitalized patients End-stage liver disease – –
Gastroenterology Nutrition in hospitalized patients Refeeding syndrome – –
Gastroenterology Diverticulosis Definition & pathobiology – –
Gastroenterology Diverticulosis Epidemiology – –
Gastroenterology Diverticulosis Clinical manifestations – –
Gastroenterology Diverticulitis Pathophysiology – –
Gastroenterology Diverticulitis Clinical manifestations – –
Gastroenterology Diverticulitis Diagnostic studies – –
Gastroenterology Diverticulitis Treatment – –
Gastroenterology Diverticulitis Prevention – –
Gastroenterology Diverticular hemorrhage Pathophysiology – –
Gastroenterology Diverticular hemorrhage Clinical manifestations – –
Gastroenterology Diverticular hemorrhage Diagnostic studies – –
Gastroenterology Diverticular hemorrhage Treatment – –
Gastroenterology Inflammatory bowel disease Definition – –
Gastroenterology Inflammatory bowel disease Epidemiology & pathophysiology – –
Gastroenterology Ulcerative colitis Clinical manifestations – –
Gastroenterology Ulcerative colitis Diagnosis – –
Gastroenterology Ulcerative colitis Complications – –
Gastroenterology Ulcerative colitis Prognosis – –
Gastroenterology Crohn's disease Clinical manifestations – –
Gastroenterology Crohn's disease Diagnosis – –
Gastroenterology Crohn's disease Complications – –
Gastroenterology Crohn's disease Prognosis – –
Gastroenterology Management of inflammatory bowel disease Initial evaluation – IBD Induction of Remission
Gastroenterology Management of inflammatory bowel disease Goals of treatment – IBD Maintenance of Remission
Gastroenterology Management of inflammatory bowel disease Complications of therapy – –
Gastroenterology Management of inflammatory bowel disease Cancer screening – –
Gastroenterology Acute mesenteric ischemia Etiologies – –
Gastroenterology Acute mesenteric ischemia Clinical manifestations – –
Gastroenterology Acute mesenteric ischemia Physical exam – –
Gastroenterology Acute mesenteric ischemia Diagnostic studies – –
Gastroenterology Acute mesenteric ischemia Treatment – –
Gastroenterology Acute mesenteric ischemia Prognosis – –
Gastroenterology Ischemic colitis Definition & pathophysiology – –
Gastroenterology Ischemic colitis Clinical manifestations, diagnosis, & treatment – –
Gastroenterology Pancreatitis Pathogenesis – –
Gastroenterology Pancreatitis Etiologies – –
Gastroenterology Pancreatitis Clinical manifestations – –
Gastroenterology Pancreatitis Physical exam – –
Gastroenterology Pancreatitis Diagnostic studies – –
Gastroenterology Pancreatitis Treatment – –
Gastroenterology Pancreatitis Complications – Ranson's Criteria
Gastroenterology Pancreatitis Prognosis – Pancreatitis Prognosis by Ranson's Criteria
Gastroenterology Pancreatitis Chronic Pancreatitis – –
Gastroenterology Abnormal liver tests Tests of hepatocellular injury or cholestasis – –
Gastroenterology Abnormal liver tests Tests of hepatic function – –
Gastroenterology Abnormal liver tests Patterns of liver injury – –
Gastroenterology Abnormal liver tests Abnormal liver tests with hepatocellular pattern Approach to abnormal liver tests with hepatocellular pattern –
Gastroenterology Abnormal liver tests Abnormal liver tests with cholestatic pattern Approach to abnormal liver tests with cholestatic pattern –
Gastroenterology Abnormal liver tests Abnormal liver tests with isolated hyperbilirubinemia Approach to abnormal liver tests with isolated hyperbilirubinemia –
Gastroenterology Abnormal liver tests Abnormal liver tests with infiltrated pattern Approach to abnormal liver tests with infiltrated pattern –
Gastroenterology Abnormal liver tests Abnormal liver tests in asymptomatic patients – –
Gastroenterology Abnormal liver tests Common medications that cause abnormal liver tests – Common medications that cause abnormal liver tests
Gastroenterology Viral hepatitis Hepatitis A – –
Gastroenterology Viral hepatitis Hepatitis B Serologic Diagnosis of Hepatitis B –
Gastroenterology Viral hepatitis Hepatitis B – Serology of Hepatitis B
Gastroenterology Viral hepatitis Hepatitis C – –
Gastroenterology Viral hepatitis Hepatitis D – –
Gastroenterology Viral hepatitis Hepatitis E – –
Gastroenterology Viral hepatitis Other Viruses – –
Gastroenterology Autoimmune hepatitis Classification – –
Gastroenterology Autoimmune hepatitis Diagnosis and treatment – –
Gastroenterology Other causes of hepatitis or hepatotoxicity Alcoholic hepatitis – –
Gastroenterology Other causes of hepatitis or hepatotoxicity Acetaminophen hepatotoxicity – –
Gastroenterology Other causes of hepatitis or hepatotoxicity Ischemic hepatitis – –
Gastroenterology Other causes of hepatitis or hepatotoxicity Nonalcoholic fatty liver disease – –
Gastroenterology Acute liver failure Definition – –
Gastroenterology Acute liver failure Etiology – –
Gastroenterology Acute liver failure Clinical manifestations – –
Gastroenterology Acute liver failure Workup – –
Gastroenterology Acute liver failure Treatment – –
Gastroenterology Acute liver failure Prognosis – –
Gastroenterology Cirrhosis Definition – –
Gastroenterology Cirrhosis Etiologies – –
Gastroenterology Cirrhosis Clinical manifestations – –
Gastroenterology Cirrhosis Physical exam – –
Gastroenterology Cirrhosis Laboratory studies – –
Gastroenterology Cirrhosis Workup – –
Gastroenterology Cirrhosis Ascites – –
Gastroenterology Cirrhosis Spontaneous bacterial peritonitis – –
Gastroenterology Cirrhosis Gastroesophageal varices ± UGIB – –
Gastroenterology Cirrhosis Portosystemic encephalopathy (PSE) – –
Gastroenterology Cirrhosis Hepatorenal syndrome (HRS) – –
Gastroenterology Cirrhosis Hepatocellular carcinoma (HCC) – –
Gastroenterology Cirrhosis Other complications – –
Gastroenterology Cirrhosis Prognosis – Modified Child-Turcotte-Pugh Scoring System
Gastroenterology Cirrhosis Liver transplantation – –
Gastroenterology Other etiologies of cirrhosis Hemochromatosis – –
Gastroenterology Other etiologies of cirrhosis Wilson's disease – –
Gastroenterology Other etiologies of cirrhosis ɑ1-antitrypsin deficiency – –
Gastroenterology Other etiologies of cirrhosis Primary biliary cirrhosis (PBC) – –
Gastroenterology Other etiologies of cirrhosis Primary sclerosing cholangitis (PSC) – –
Gastroenterology Hepatic vascular disease Portal vein thrombosis – –
Gastroenterology Hepatic vascular disease Budd-Chiari syndrome – –
Gastroenterology Hepatic vascular disease Sinusoidal obstruction syndrome Hepatic vasculature –
Gastroenterology Ascites Pathophysiology – Etiologies of Ascites
Gastroenterology Ascites Symptoms – –
Gastroenterology Ascites Evaluation – –
Gastroenterology Ascites Treatment – –
Gastroenterology Ascites Bacterial peritonitis – Ascites in Bacterial peritonitis
Gastroenterology Cholelithiasis Epidemiology & pathogenesis – –
Gastroenterology Cholelithiasis Types of gallstones – –
Gastroenterology Cholelithiasis Clinical manifestations – –
Gastroenterology Cholelithiasis Diagnostic studies – –
Gastroenterology Cholelithiasis Treatment – –
Gastroenterology Cholelithiasis Complications – –
Gastroenterology Cholecystitis Pathogenesis – –
Gastroenterology Cholecystitis Clinical manifestations – –
Gastroenterology Cholecystitis Diagnostic studies – –
Gastroenterology Cholecystitis Treatment – –
Gastroenterology Cholecystitis Complications – –
Gastroenterology Choledocholithiasis Definition – –
Gastroenterology Choledocholithiasis Epidemiology – –
Gastroenterology Choledocholithiasis Clinical manifestations – –
Gastroenterology Choledocholithiasis Diagnostic studies – –
Gastroenterology Choledocholithiasis Treatment – –
Gastroenterology Choledocholithiasis Complications – –
Gastroenterology Cholangitis Definition & etiologies – –
Gastroenterology Cholangitis Clinical manifestations – –
Gastroenterology Cholangitis Diagnostic studies – –
Gastroenterology Cholangitis Treatment – –
Nephrology Acid-base disturbances Consequences of Severe Acid-Base Disturbances – Consequences of Severe Acid-Base Disturbances
Nephrology Acid-base disturbances Workup – Acid-Base Disturbances
Nephrology Acid-base disturbances Compensation for Acid-Base Disturbances – Compensation for Acid-Base Disturbances
Nephrology Acid-base disturbances Acid-base nomogram Acid-base nomogram –
Nephrology Metabolic acidosis Initial workup Approach to metabolic acidosis –
Nephrology Metabolic acidosis Etiologies of AG metabolic acidosis – Etiologies of AG metabolic acidosis
Nephrology Metabolic acidosis Workup for AG metabolic acidosis – Manifestations of ingestions causing AG metabolic acidosis
Nephrology Metabolic acidosis Workup for non-AG metabolic acidosis – Etiologies of non-AG metabolic acidosis
Nephrology Metabolic acidosis Renal tubular acidosis – Renal tubular acidosis
Nephrology Metabolic acidosis Treatment of severe metabolic acidosis – –
Nephrology Metabolic alkalosis Pathophysiology – –
Nephrology Metabolic alkalosis Workup Approach to metabolic alkalosis –
Nephrology Metabolic alkalosis Etiologies of metabolic alkalosis – Etiologies of metabolic alkalosis
Nephrology Metabolic alkalosis Treatment of severe metabolic alkalosis – –
Nephrology Respiratory acidosis Respiratory Acidosis – –
Nephrology Respiratory alkalosis Respiratory Alkalosis – –
Nephrology Hyponatremia Pathophysiology Approach to hyponatremia –
Nephrology Hyponatremia Workup – –
Nephrology Hyponatremia Hypovolemic hypotonic hyponatremia – –
Nephrology Hyponatremia Euvolemic hypotonic hyponatremia – –
Nephrology Hyponatremia Hypervolemic hypotonic hyponatremia – –
Nephrology Hyponatremia Treatment – –
Nephrology Hypernatremia Pathophysiology Approach to hypernatremia –
Nephrology Hypernatremia Workup – –
Nephrology Hypernatremia Extrarenal H2O loss – –
Nephrology Hypernatremia Renal H2O loss – –
Nephrology Hypernatremia Other – –
Nephrology Hypernatremia Treatment – –
Nephrology Polyuria Definition and pathophysiology Approach to polyuria –
Nephrology Polyuria Workup – –
Nephrology Polyuria Osmotic diuresis – –
Nephrology Polyuria Water diuresis – –
Nephrology Polyuria Treatment – –
Nephrology Hypokalemia Transcellular shifts Approach to hypokalemia –
Nephrology Hypokalemia GI potassium losses – –
Nephrology Hypokalemia Renal potassium losses – –
Nephrology Hypokalemia Clinical manifestations – –
Nephrology Hypokalemia Workup – –
Nephrology Hypokalemia Treatment – –
Nephrology Hyperkalemia Transcellular shifts – –
Nephrology Hyperkalemia Decreased GFR – –
Nephrology Hyperkalemia Normal GFR but with Ø renal K excretion – –
Nephrology Hyperkalemia Clinical manifestations – –
Nephrology Hyperkalemia Workup – Treatment of Hyperkalemia
Nephrology Acute kidney injury Definition – –
Nephrology Acute kidney injury Workup – Etiologies and Diagnosis of Acute Kidney Injury
Nephrology Acute kidney injury Contrast-induced acute kidney injury (CIAKI) – –
Nephrology Acute kidney injury Treatment – –
Nephrology Chronic kidney disease Definition and etiologies – Stages of CKD
Nephrology Chronic kidney disease Treatment – Signs and Symptoms of Uremia
Nephrology Diuresis General considerations – Approach to Diuresis
Nephrology Diuresis Loop diuretics – –
Nephrology Diuresis Thiazide diuretics – –
Nephrology Diuresis K-sparing diuretics – –
Nephrology Diuresis Disease state specific regimens – –
Nephrology Diuresis Adverse effects – –
Nephrology Renal replacement and dialysis General – –
Nephrology Renal replacement and dialysis Hemodialysis (HD) – –
Nephrology Renal replacement and dialysis Continuous veno-venous hemofiltration (CVVH) – –
Nephrology Renal replacement and dialysis Peritoneal dialysis (PD) – –
Nephrology Renal replacement and dialysis Kidney transplantation – –
Nephrology Glomerulonephritis Definition Approach to glomerulonephritis –
Nephrology Glomerulonephritis ANCA-Positive Vasculitis – ANCA-Positive Vasculitis
Nephrology Glomerulonephritis Anti-GBM Disease – Anti-GBM Disease
Nephrology Glomerulonephritis Immune Complex Disease – Immune Complex Disease
Nephrology Glomerulonephritis Workup – –
Nephrology Glomerulonephritis Treatment – –
Nephrology Asymptomatic glomerular hematuria Definition and etiologies – –
Nephrology Asymptomatic glomerular hematuria IgA nephropathy – –
Nephrology Nephrotic syndrome Definition – –
Nephrology Nephrotic syndrome Primary glomerular diseases – –
Nephrology Nephrotic syndrome Systemic diseases – –
Nephrology Nephrotic syndrome Workup – –
Nephrology Nephrotic syndrome Treatment – –
Nephrology Urinalysis Urine Dipstick – Urine Dipstick
Nephrology Urinalysis Urine Sediment – Urine Sediment
Nephrology Proteinuria Proteinuria – Etiologies of Proteinuria
Nephrology Hematuria Workup – Etiologies of Hematuria
Nephrology Nephrolithiasis Types of stones and risk factors – –
Nephrology Nephrolithiasis Clinical manifestations – –
Nephrology Nephrolithiasis Workup – –
Nephrology Nephrolithiasis Acute treatment – –
Nephrology Nephrolithiasis Chronic treatment – –
Hematology-Oncology Anemia Clinical manifestations – –
Hematology-Oncology Anemia Diagnostic evaluation Approach to anemia –
Hematology-Oncology Microcytic anemia Approach to microcytic anemias Approach to microcytic anemias –
Hematology-Oncology Microcytic anemia Iron deficiency – –
Hematology-Oncology Microcytic anemia Thalassemias – –
Hematology-Oncology Microcytic anemia Anemia of chronic inflammation – –
Hematology-Oncology Microcytic anemia Sideroblastic anemia – –
Hematology-Oncology Normocytic anemia Pancytopenia – –
Hematology-Oncology Normocytic anemia Anemia of chronic inflammation – –
Hematology-Oncology Normocytic anemia Anemias of chronic disorders – –
Hematology-Oncology Normocytic anemia Sideroblastic anemia – –
Hematology-Oncology Normocytic anemia Pure red cell aplasia – –
Hematology-Oncology Macrocytic anemia Megaloblastic anemia – –
Hematology-Oncology Macrocytic anemia Folate deficiency – –
Hematology-Oncology Macrocytic anemia Vitamin B12 deficiency – –
Hematology-Oncology Macrocytic anemia Nonmegaloblastic macrocytic anemias – –
Hematology-Oncology Pancytopenia Etiologies – –
Hematology-Oncology Pancytopenia Clinical manifestations – –
Hematology-Oncology Pancytopenia Aplastic anemia – –
Hematology-Oncology Pancytopenia Myelodysplastic syndromes (MDS) – –
Hematology-Oncology Pancytopenia Paroxysmal nocturnal hemoglobinuria (PNH) – –
Hematology-Oncology Pancytopenia Myelophthisic anemia – –
Hematology-Oncology Hemolytic anemia Diagnostic evaluation – Causes of Hemolytic Anemia by Mechanism
Hematology-Oncology Hemolytic anemia Glucose-6-phosphate dehydrogenase (G6PD) deficiency – –
Hematology-Oncology Hemolytic anemia Sickle cell anemia – –
Hematology-Oncology Hemolytic anemia Hereditary spherocytosis (HS) – –
Hematology-Oncology Hemolytic anemia Autoimmune hemolytic anemia (AIHA) – –
Hematology-Oncology Hemolytic anemia Drug-induced hemolytic anemia – –
Hematology-Oncology Hemolytic anemia Microangiopathic hemolytic anemia (MAHA) – –
Hematology-Oncology Hemolytic anemia Hypersplenism – Causes of Splenomegaly
Hematology-Oncology Disorders of hemostasis Approach to abnormal hemostasis Approach to abnormal hemostasis –
Hematology-Oncology Disorders of hemostasis Clinical Characteristics of Bleeding Disorders – Clinical Characteristics of Bleeding Disorders
Hematology-Oncology Disorders of hemostasis Coagulation Cascade Coagulation Cascade –
Hematology-Oncology Disorders of hemostasis Purpura – –
Hematology-Oncology Thrombocytopenia Etiologies Approach to thrombocytopenia –
Hematology-Oncology Thrombocytopenia Thrombocytopenia and Risk of Bleeding – Thrombocytopenia and Risk of Bleeding
Hematology-Oncology Thrombocytopenia Diagnostic evaluation – –
Hematology-Oncology Thrombocytopenia Primary immune thrombocytopenic purpura (ITP) – Treatment of Primary ITP in Adults
Hematology-Oncology Thrombocytopenia Heparin-Induced Thrombocytopenia – Overview of Heparin-Induced Thrombocytopenia
Hematology-Oncology Thrombocytopenia Evaluation of Suspected HIT – Evaluation of Suspected HIT
Hematology-Oncology Thrombocytopenia Hemolytic-uremic syndrome (HUS) – –
Hematology-Oncology Thrombocytopenia Thrombotic thrombocytopenic purpura (TTP) – –
Hematology-Oncology Disorders of platelet function Tests of platelet function – Mechanisms and Etiologies of Platelet Function Abnormalities
Hematology-Oncology Disorders of platelet function von Willebrand’s disease (vWD) – –
Hematology-Oncology Disorders of platelet function Uremic bleeding – –
Hematology-Oncology Coagulopathies Screening Test Abnormalities in Inherited and Acquired Coagulopathies – Screening Test Abnormalities in Inherited and Acquired Coagulopathies
Hematology-Oncology Coagulopathies Further coagulation tests – –
Hematology-Oncology Coagulopathies Hemophilias – –
Hematology-Oncology Coagulopathies Coagulation factor inhibitors – –
Hematology-Oncology Coagulopathies Disseminated intravascular coagulation (DIC) – –
Hematology-Oncology Coagulopathies Vitamin K deficiency – Properties and Antidotes for Anticoagulants and Fibrinolytics
Hematology-Oncology Hypercoagulable states Inherited Hypercoagulable States – Inherited Hypercoagulable States
Hematology-Oncology Hypercoagulable states Vascular Beds Affected by Inherited and Acquired Hypercoagulable States – Vascular Beds Affected by Inherited and Acquired Hypercoagulable States
Hematology-Oncology Hypercoagulable states Diagnostic evaluation – –
Hematology-Oncology Hypercoagulable states Treatment – –
Hematology-Oncology Hypercoagulable states Antiphospholipid syndrome (APS) – –
Hematology-Oncology Disorders of leukocytes Neutrophilia – Neutrophilia
Hematology-Oncology Disorders of leukocytes Neutropenia – Neutropenia
Hematology-Oncology Disorders of leukocytes Lymphocytosis – Lymphocytosis
Hematology-Oncology Disorders of leukocytes Monocytosis – Monocytosis
Hematology-Oncology Disorders of leukocytes Eosinophilia – Eosinophilia
Hematology-Oncology Disorders of leukocytes Basophilia – Basophilia
Hematology-Oncology Disorders of leukocytes Lymphadenopathy – Lymphadenopathy
Hematology-Oncology Transfusion therapy Blood Products and Indications – Blood Products and Indications
Hematology-Oncology Transfusion therapy Transfusion Complications – Transfusion Complications
Hematology-Oncology Transfusion therapy Transfusion Reactions – Transfusion Reactions
Hematology-Oncology Myelodysplastic syndromes Myeloid neoplasm overview – WHO 2008 Myeloid Neoplasm Categories
Hematology-Oncology Myelodysplastic syndromes Myelodysplastic syndromes (MDS) overview – WHO 2008 Classification Systems for MDS
Hematology-Oncology Myelodysplastic syndromes Revised International Prognostic Scoring System – Revised International Prognostic Scoring System for AML
Hematology-Oncology Myeloproliferative neoplasms (mpn) Myeloproliferative Neoplasms (MPN) – –
Hematology-Oncology Polycythemia vera (pv) Definition – –
Hematology-Oncology Polycythemia vera (pv) Etiologies of erythrocytosis – –
Hematology-Oncology Polycythemia vera (pv) Clinical manifestations – –
Hematology-Oncology Polycythemia vera (pv) Diagnostic evaluation – –
Hematology-Oncology Polycythemia vera (pv) Treatment – –
Hematology-Oncology Polycythemia vera (pv) Prognosis – –
Hematology-Oncology Essential thrombocythemia (et) Definition – –
Hematology-Oncology Essential thrombocythemia (et) Etiologies of thrombocytosis – –
Hematology-Oncology Essential thrombocythemia (et) Clinical manifestations – –
Hematology-Oncology Essential thrombocythemia (et) Diagnostic evaluation – –
Hematology-Oncology Essential thrombocythemia (et) Prognosis – –
Hematology-Oncology Primary myelofibrosis (pmf) Definition – –
Hematology-Oncology Primary myelofibrosis (pmf) Etiologies of myelofibrosis – –
Hematology-Oncology Primary myelofibrosis (pmf) Clinical manifestations – –
Hematology-Oncology Primary myelofibrosis (pmf) Diagnostic evaluation – –
Hematology-Oncology Primary myelofibrosis (pmf) Treatment – –
Hematology-Oncology Primary myelofibrosis (pmf) Complications and prognosis – –
Hematology-Oncology Acute leukemia Definition – –
Hematology-Oncology Acute leukemia Epidemiology and risk factors – –
Hematology-Oncology Acute leukemia Clinical manifestations – –
Hematology-Oncology Acute leukemia Diagnostic evaluation – –
Hematology-Oncology Acute myelogenous leukemia (aml) Classification – WHO 2008 Classification of AML
Hematology-Oncology Acute myelogenous leukemia (aml) Treatment – AML Genetics
Hematology-Oncology Acute myelogenous leukemia (aml) Prognosis – –
Hematology-Oncology Acute myelogenous leukemia (aml) Acute Promyelocytic Leukemia (APL) – –
Hematology-Oncology Acute lymphoblastic leukemia (all) Classification – WHO Immunophenotype Classification of ALL
Hematology-Oncology Acute lymphoblastic leukemia (all) Treatment – –
Hematology-Oncology Acute lymphoblastic leukemia (all) Prognosis – –
Hematology-Oncology Chronic myelogenous leukemia (cml) Definition – –
Hematology-Oncology Chronic myelogenous leukemia (cml) Epidemiology and risk factors – –
Hematology-Oncology Chronic myelogenous leukemia (cml) Clinical manifestations – –
Hematology-Oncology Chronic myelogenous leukemia (cml) Diagnostic evaluation – –
Hematology-Oncology Chronic myelogenous leukemia (cml) Treatment – Goals of TKI Therapy
Hematology-Oncology Chronic myelogenous leukemia (cml) Prognosis – –
Hematology-Oncology Chronic lymphocytic leukemia (cll) Definition – –
Hematology-Oncology Chronic lymphocytic leukemia (cll) Epidemiology and risk factors – –
Hematology-Oncology Chronic lymphocytic leukemia (cll) Clinical manifestations – –
Hematology-Oncology Chronic lymphocytic leukemia (cll) Diagnostic evaluation – CLL Staging
Hematology-Oncology Chronic lymphocytic leukemia (cll) Treatment – –
Hematology-Oncology Chronic lymphocytic leukemia (cll) Prognosis – –
Hematology-Oncology Lymphoma Definition – –
Hematology-Oncology Lymphoma Clinical manifestations – –
Hematology-Oncology Lymphoma Diagnostic and staging evaluation – Ann Arbor Staging System with Cotswolds Modifications
Hematology-Oncology Hodgkin lymphoma (hl) Epidemiology and risk factors – –
Hematology-Oncology Hodgkin lymphoma (hl) Pathology – WHO Histologic Classification of Classical HL
Hematology-Oncology Hodgkin lymphoma (hl) Treatment – International Prognostic Score (IPS)
Hematology-Oncology Non-hodgkin lymphoma (nhl) Epidemiology and risk factors – WHO Classification of Lymphoid Malignancies
Hematology-Oncology Non-hodgkin lymphoma (nhl) Treatment – –
Hematology-Oncology Non-hodgkin lymphoma (nhl) Prognosis – Follicular Lymphoma International Prognostic Index (FLIPI)
Hematology-Oncology Non-hodgkin lymphoma (nhl) HIV-associated NHL – International Prognostic Index (IPI) for Aggressive NHL
Hematology-Oncology Multiple myeloma Definition and epidemiology – –
Hematology-Oncology Multiple myeloma Clinical manifestations – –
Hematology-Oncology Multiple myeloma Diagnostic and staging evaluation – Multiple Myeloma Staging Systems
Hematology-Oncology Multiple myeloma Treatment – –
Hematology-Oncology Monoclonal gammopathy of uncertain significance Definition and epidemiology – –
Hematology-Oncology Monoclonal gammopathy of uncertain significance Management – –
Hematology-Oncology Monoclonal gammopathy of uncertain significance Prognosis – –
Hematology-Oncology Waldenstrom's macroglobulinemia Definition – –
Hematology-Oncology Waldenstrom's macroglobulinemia Clinical manifestations – –
Hematology-Oncology Waldenstrom's macroglobulinemia Diagnostic evaluation – –
Hematology-Oncology Waldenstrom's macroglobulinemia Treatment – –
Hematology-Oncology Hematopoietic stem cell transplantation Indications – Categories of Stem Cell Transplantation
Hematology-Oncology Hematopoietic stem cell transplantation Transplantation procedure – Prophylaxis and Supportive Medications during HSCT
Hematology-Oncology Hematopoietic stem cell transplantation Complications – Timing of Complications following Allogeneic HSCT
Hematology-Oncology Lung cancer Pathology and Genetics of Lung Cancer – Pathology and Genetics of Lung Cancer
Hematology-Oncology Lung cancer Epidemiology and risk factors – –
Hematology-Oncology Lung cancer Clinical manifestations – –
Hematology-Oncology Lung cancer Screening – –
Hematology-Oncology Lung cancer Diagnostic and staging evaluation – TNM Staging System for NSCLC
Hematology-Oncology Lung cancer NSCLC Treatment – NSCLC Simplified Staging Schema
Hematology-Oncology Lung cancer SCLC Treatment – –
Hematology-Oncology Breast cancer Epidemiology and genetics – –
Hematology-Oncology Breast cancer Clinical manifestations – –
Hematology-Oncology Breast cancer Screening – –
Hematology-Oncology Breast cancer Diagnostic evaluation – –
Hematology-Oncology Breast cancer Staging – Simplified Staging System for Breast Cancer
Hematology-Oncology Breast cancer Treatment – Treatment of Carcinoma in situ and Invasive Carcinoma of the Breast
Hematology-Oncology Breast cancer Prevention – –
Hematology-Oncology Prostate cancer Epidemiology and risk factors – –
Hematology-Oncology Prostate cancer Clinical manifestations – –
Hematology-Oncology Prostate cancer Screening – –
Hematology-Oncology Prostate cancer Diagnostic and staging evaluation – TNM Staging and Treatment of Prostate Cancer
Hematology-Oncology Prostate cancer Prognosis – –
Hematology-Oncology Prostate cancer Prevention – –
Hematology-Oncology Colorectal cancer Epidemiology and risk factors – –
Hematology-Oncology Colorectal cancer Pathology and genetics – –
Hematology-Oncology Colorectal cancer Clinical manifestations – –
Hematology-Oncology Colorectal cancer Screening – –
Hematology-Oncology Colorectal cancer Staging – Treatment Based on TNM and Modified Dukes Staging of Colorectal Cancer
Hematology-Oncology Chemotherapy side effects Chemotherapy Side Effects – Select Adverse Effects from Chemotherapy
Hematology-Oncology Pancreatic tumors Pathology and genetics – –
Hematology-Oncology Pancreatic tumors Epidemiology and risk factors – –
Hematology-Oncology Pancreatic tumors Clinical manifestations – –
Hematology-Oncology Pancreatic tumors Diagnostic and staging evaluation – Staging and Prognosis of Pancreatic Adenocarcinoma
Hematology-Oncology Pancreatic tumors Treatment of pancreatic adenocarcinoma – –
Hematology-Oncology Pancreatic tumors Cystic lesions of the pancreas – –
Hematology-Oncology Fever and neutropenia Definition – –
Hematology-Oncology Fever and neutropenia Pathophysiology and microbiology – –
Hematology-Oncology Fever and neutropenia Prevention – –
Hematology-Oncology Fever and neutropenia Diagnostic evaluation – –
Hematology-Oncology Fever and neutropenia Risk stratification – –
Hematology-Oncology Fever and neutropenia Initial antibiotic therapy – –
Hematology-Oncology Fever and neutropenia Modification to initial antibiotic regimen – –
Hematology-Oncology Fever and neutropenia Duration of therapy – –
Hematology-Oncology Fever and neutropenia Role of hematopoietic growth factors – –
Hematology-Oncology Spinal cord compression Clinical manifestations – –
Hematology-Oncology Spinal cord compression Diagnostic evaluation – –
Hematology-Oncology Spinal cord compression Treatment – –
Hematology-Oncology Tumor lysis syndrome Clinical manifestations – –
Hematology-Oncology Tumor lysis syndrome Prophylaxis – –
Hematology-Oncology Tumor lysis syndrome Treatment – –
Hematology-Oncology Cancer of unknown primary site Cancer of Unknown Primary Site – Evaluation of Cancer of Unknown Primary Site
Infectious Diseases Pneumonia Microbiology of Pneumonia – Microbiology of Pneumonia
Infectious Diseases Pneumonia Clinical manifestations – –
Infectious Diseases Pneumonia Diagnostic studies – –
Infectious Diseases Pneumonia Prognosis – –
Infectious Diseases Pneumonia Treatment – Treatment of Pneumonia
Infectious Diseases Pneumonia Prevention – –
Infectious Diseases Viral respiratory infections Microbiology & epidemiology – –
Infectious Diseases Viral respiratory infections Diagnosis – –
Infectious Diseases Viral respiratory infections Treatment – –
Infectious Diseases Viral respiratory infections Prevention – –
Infectious Diseases Fungal infections Candida species – Treatment of Candidiasis
Infectious Diseases Fungal infections Cryptococcus – –
Infectious Diseases Fungal infections Histoplasmosis – –
Infectious Diseases Fungal infections Coccidioidomycosis – –
Infectious Diseases Fungal infections Blastomycosis – –
Infectious Diseases Fungal infections Aspergillosis – –
Infectious Diseases Fungal infections Zygomycetes – –
Infectious Diseases Fungal infections Fungal diagnostics – –
Infectious Diseases Infections in immunocompromised hosts Classic Infectious Etiologies in Immunocompromised Hosts – Classic Infectious Etiologies in Immunocompromised Hosts
Infectious Diseases Urinary tract infection Definitions – –
Infectious Diseases Urinary tract infection Microbiology – –
Infectious Diseases Urinary tract infection Clinical manifestations – –
Infectious Diseases Urinary tract infection Diagnostic studies – –
Infectious Diseases Urinary tract infection Treatment – Treatment of UTI
Infectious Diseases Cellulitis Microbiology & clinical – –
Infectious Diseases Cellulitis Diagnosis – Microbiology of Bite Infections
Infectious Diseases Cellulitis Treatment – Treatment of Cellulitis
Infectious Diseases Other cutaneous infections Other Cutaneous Infections – Other Cutaneous Infections
Infectious Diseases Diabetic foot Microbiology – –
Infectious Diseases Diabetic foot Clinical manifestations – –
Infectious Diseases Diabetic foot Diagnostic studies – –
Infectious Diseases Diabetic foot Treatment – Treatment of Diabetic Foot
Infectious Diseases Necrotizing fasciitis Definition – –
Infectious Diseases Necrotizing fasciitis Epidemiology – –
Infectious Diseases Necrotizing fasciitis Microbiology – –
Infectious Diseases Necrotizing fasciitis Clinical manifestations – –
Infectious Diseases Necrotizing fasciitis Diagnostic signs – –
Infectious Diseases Necrotizing fasciitis Treatment – –
Infectious Diseases Necrotizing fasciitis Prognosis – –
Infectious Diseases Clostridial myonecrosis Definition – –
Infectious Diseases Clostridial myonecrosis Clinical manifestations – –
Infectious Diseases Clostridial myonecrosis Diagnostic signs – –
Infectious Diseases Clostridial myonecrosis Treatment – –
Infectious Diseases Osteomyelitis Microbiology – –
Infectious Diseases Osteomyelitis Clinical manifestations – –
Infectious Diseases Osteomyelitis Diagnostic studies – –
Infectious Diseases Osteomyelitis Treatment – –
Infectious Diseases Epidural abscess Etiology – –
Infectious Diseases Epidural abscess Clinical manifestations – –
Infectious Diseases Epidural abscess Diagnostic studies – –
Infectious Diseases Epidural abscess Treatment – –
Infectious Diseases Acute bacterial meningitis Definition – Microbiology in Adult Meningitis
Infectious Diseases Acute bacterial meningitis Clinical manifestations – –
Infectious Diseases Acute bacterial meningitis Physical exam – –
Infectious Diseases Acute bacterial meningitis Diagnostic studies – –
Infectious Diseases Acute bacterial meningitis Recurrent meningitis – Typical CSF Findings in Meningitis
Infectious Diseases Acute bacterial meningitis Treatment – Treatment of Meningitis
Infectious Diseases Acute bacterial meningitis Prognosis – –
Infectious Diseases Aseptic meningitis Definition – –
Infectious Diseases Aseptic meningitis Etiologies – –
Infectious Diseases Aseptic meningitis Empiric treatment – –
Infectious Diseases Encephalitis Definition – –
Infectious Diseases Encephalitis Etiologies – –
Infectious Diseases Encephalitis Clinical manifestations – –
Infectious Diseases Encephalitis Diagnostic studies – –
Infectious Diseases Encephalitis Treatment – –
Infectious Diseases Bell's palsy Definition & etiologies – –
Infectious Diseases Bell's palsy Clinical manifestations – –
Infectious Diseases Bell's palsy Diagnosis – –
Infectious Diseases Bell's palsy Treatment – –
Infectious Diseases Zoster Definition & etiology – –
Infectious Diseases Zoster Clinical manifestations – –
Infectious Diseases Zoster Diagnosis – –
Infectious Diseases Zoster Treatment – –
Infectious Diseases Bacterial endocarditis Definition – Microbiology of Endocarditis
Infectious Diseases Bacterial endocarditis Predisposing conditions – Modified Duke Criteria for Endocarditis
Infectious Diseases Bacterial endocarditis Clinical manifestations – –
Infectious Diseases Bacterial endocarditis Physical exam – –
Infectious Diseases Bacterial endocarditis Diagnostic studies – –
Infectious Diseases Bacterial endocarditis Treatment – –
Infectious Diseases Bacterial endocarditis Indications for surgery – –
Infectious Diseases Bacterial endocarditis Prognosis – Endocarditis prophylaxis
Infectious Diseases Bacteremia Etiologies – –
Infectious Diseases Bacteremia Microbiology – –
Infectious Diseases Bacteremia Risk factors for true bacteremia – –
Infectious Diseases Bacteremia Diagnosis – –
Infectious Diseases Bacteremia Treatment – –
Infectious Diseases Tuberculosis Epidemiology – –
Infectious Diseases Tuberculosis Microbiology & natural history – –
Infectious Diseases Tuberculosis Screening for prior infection – –
Infectious Diseases Tuberculosis Clinical manifestations – –
Infectious Diseases Tuberculosis Diagnostic studies for active TB – –
Infectious Diseases Tuberculosis Preventive therapy – Prophylactic Regimen for TB
Infectious Diseases Tuberculosis Treatment of active tuberculosis – Antituberculous Medications
Infectious Diseases Tuberculosis Antituberculous Treatment Regimens – Antituberculous Treatment Regimens
Infectious Diseases Hiv/aids Definition – –
Infectious Diseases Hiv/aids Epidemiology – –
Infectious Diseases Hiv/aids Acute retroviral syndrome – –
Infectious Diseases Hiv/aids Diagnostic studies – –
Infectious Diseases Hiv/aids Approach to newly diagnosed HIV pt – Antiretrovirals and Side Effects
Infectious Diseases Hiv/aids Approach to previously established HIV pt – –
Infectious Diseases Hiv/aids Opportunistic infection prophylaxis – Opportunistic infection prophylaxis
Infectious Diseases Complications of hiv/aids Fever – –
Infectious Diseases Complications of hiv/aids Cutaneous – –
Infectious Diseases Complications of hiv/aids Ophthalmologic – –
Infectious Diseases Complications of hiv/aids Oral – –
Infectious Diseases Complications of hiv/aids Endocrine/metabolic – –
Infectious Diseases Complications of hiv/aids Cardiac – –
Infectious Diseases Complications of hiv/aids Pulmonary – –
Infectious Diseases Complications of hiv/aids Gastrointestinal & hepatobiliary – –
Infectious Diseases Complications of hiv/aids Renal – –
Infectious Diseases Complications of hiv/aids Hematologic/oncologic – –
Infectious Diseases Complications of hiv/aids Neurologic – –
Infectious Diseases Complications of hiv/aids Disseminated Mycobacterium avium complex – –
Infectious Diseases Complications of hiv/aids Cytomegalovirus – –
Infectious Diseases Tick-borne illness Distinguishing features of tick-borne illnesses – Distinguishing features of tick-borne illnesses
Infectious Diseases Lyme disease Microbiology – –
Infectious Diseases Lyme disease Epidemiology – –
Infectious Diseases Lyme disease Diagnostic studies – –
Infectious Diseases Lyme disease Treatment – –
Infectious Diseases Rocky mountain spotted fever Microbiology & epidemiology – –
Infectious Diseases Rocky mountain spotted fever Clinical manifestations – –
Infectious Diseases Rocky mountain spotted fever Diagnosis – –
Infectious Diseases Rocky mountain spotted fever Treatment – –
Infectious Diseases Ehrlichiosis/anaplasmosis Microbiology – –
Infectious Diseases Ehrlichiosis/anaplasmosis Epidemiology – –
Infectious Diseases Ehrlichiosis/anaplasmosis Clinical manifestations – –
Infectious Diseases Ehrlichiosis/anaplasmosis Diagnosis – –
Infectious Diseases Ehrlichiosis/anaplasmosis Treatment – –
Infectious Diseases Babesiosis Microbiology & epidemiology – –
Infectious Diseases Babesiosis Clinical manifestations – –
Infectious Diseases Babesiosis Diagnosis – –
Infectious Diseases Babesiosis Treatment – –
Infectious Diseases Tularemia Microbiology – –
Infectious Diseases Tularemia Clinical manifestations – –
Infectious Diseases Tularemia Diagnosis & treatment – –
Infectious Diseases Fever syndromes Diagnosis approach – –
Infectious Diseases Fever of unknown origin Definition & etiologies – Etiologies of Classic FUO
Infectious Diseases Fever of unknown origin Workup – –
Infectious Diseases Fever of unknown origin Treatment – –
Infectious Diseases Fever and rash Approach to diagnostic workup – Possible Etiology
Infectious Diseases Fever and rash Treatment – –
Infectious Diseases Fever in a returned traveler Definition & etiologies – Common Etiologies of Fever in A Returned Traveler
Infectious Diseases Fever in a returned traveler Select clinical manifestations – –
Infectious Diseases Fever in a returned traveler Workup – –
Endocrinology Hypopituitary syndromes Panhypopituitarism – –
Endocrinology Hyperpituitary syndromes Pituitary tumors – –
Endocrinology Hyperpituitary syndromes Hyperprolactinemia – –
Endocrinology Hyperpituitary syndromes Acromegaly – –
Endocrinology Hyperpituitary syndromes Cushing's disease – –
Endocrinology Hyperpituitary syndromes Central hyperthyroidism – –
Endocrinology Hyperpituitary syndromes Multiple Endocrine Neoplasia Syndromes – Multiple Endocrine Neoplasia Syndromes
Endocrinology Hyperpituitary syndromes Polyglandular Autoimmune Syndromes – Polyglandular Autoimmune Syndromes
Endocrinology Thyroid disorders Diagnostic Studies in Thyroid Disorders – Diagnostic Studies in Thyroid Disorders
Endocrinology Thyroid disorders Approach to Thyroid Disorders Approach to Thyroid Disorders –
Endocrinology Hypothyroidism Etiologies – –
Endocrinology Hypothyroidism Hashimoto's thyroiditis – –
Endocrinology Hypothyroidism Clinical manifestations – –
Endocrinology Hypothyroidism Diagnostic studies – –
Endocrinology Hypothyroidism Treatment of overt hypothyroidism – –
Endocrinology Hypothyroidism Subclinical hypothyroidism – –
Endocrinology Hyperthyroidism Etiologies – –
Endocrinology Hyperthyroidism Clinical manifestations of hyperthyroidism – –
Endocrinology Hyperthyroidism Laboratory testing – –
Endocrinology Hyperthyroidism Graves' disease – –
Endocrinology Hyperthyroidism Thyroiditis – –
Endocrinology Hyperthyroidism Treatment – –
Endocrinology Hyperthyroidism Subclinical hyperthyroidism – –
Endocrinology Nonthyroidal illness Sick euthyroid syndrome – –
Endocrinology Amiodarone and thyroid disease Amiodarone-induced hypothyroidism – –
Endocrinology Amiodarone and thyroid disease Amiodarone-induced hyperthyroidism – –
Endocrinology Thyroid nodules Approach to thyroid nodules Approach to thyroid nodules –
Endocrinology Cushing's syndrome Definitions – –
Endocrinology Cushing's syndrome Etiologies of hypercortisolism – –
Endocrinology Cushing's syndrome Clinical manifestations Approach to suspected Cushing's syndrome –
Endocrinology Cushing's syndrome Treatment of Cushing's syndrome – –
Endocrinology Hyperaldosteronism Etiologies – –
Endocrinology Hyperaldosteronism Clinical manifestations – –
Endocrinology Hyperaldosteronism Diagnostic studies Approach to suspected hyperaldosteronism –
Endocrinology Hyperaldosteronism Treatment – –
Endocrinology Adrenal insufficiency Etiologies – –
Endocrinology Adrenal insufficiency Clinical manfiestations – –
Endocrinology Adrenal insufficiency Diagnostic studies – –
Endocrinology Adrenal insufficiency Adrenal insufficiency & critical illness – –
Endocrinology Adrenal insufficiency Treatment – –
Endocrinology Pheochromocytoma Clinical manifestations – –
Endocrinology Pheochromocytoma Diagnostic studies – –
Endocrinology Pheochromocytoma Treatment – –
Endocrinology Adrenal incidentalomas Epidemiology – –
Endocrinology Adrenal incidentalomas Differential diagnosis – –
Endocrinology Adrenal incidentalomas Workup – –
Endocrinology Calcium disorders Pitfalls in measuring calcium – Laboratory Findings in Calcium Disorders
Endocrinology Hypercalcemia Clinical manifestations – Etiologies of Hypercalcemia
Endocrinology Hypercalcemia Diagnostic studies – –
Endocrinology Hypercalcemia Treatment – Treatment of Hypercalcemia
Endocrinology Hypercalcemia Treatment of asymptomatic primary HPT – –
Endocrinology Hypocalcemia Clinical manifestations – Etiologies of Hypocalcemia
Endocrinology Hypocalcemia Diagnostic studies – –
Endocrinology Hypocalcemia Treatment – –
Endocrinology Diabetes mellitus Definition – –
Endocrinology Diabetes mellitus Categories – –
Endocrinology Diabetes mellitus Clinical manifestations – –
Endocrinology Diabetes mellitus Treatment – Diabetes Treatment Options
Endocrinology Diabetes mellitus Insulin Preparations – Insulin Preparations
Endocrinology Diabetes mellitus Complications – –
Endocrinology Diabetes mellitus Outpatient screening and treatment goals – –
Endocrinology Diabetes mellitus Management of hyperglycemia in inpatients – –
Endocrinology Diabetic ketoacidosis Precipitants – –
Endocrinology Diabetic ketoacidosis Pathophysiology – –
Endocrinology Diabetic ketoacidosis Clinical manifestations – –
Endocrinology Diabetic ketoacidosis Diagnostic studies – Typical DKA Flow Sheet Setup
Endocrinology Diabetic ketoacidosis Treatment – Treatment of DKA
Endocrinology Hyperosmolar hyperglycemic state Definition, precipitants, pathophysiology – –
Endocrinology Hyperosmolar hyperglycemic state Clinical manifestations & dx studies – –
Endocrinology Hyperosmolar hyperglycemic state Treatment – –
Endocrinology Hypoglycemia Clinical manifestations – –
Endocrinology Hypoglycemia Etiologies in diabetics – –
Endocrinology Hypoglycemia Etiologies in nondiabetics – –
Endocrinology Hypoglycemia Evaluation in nondiabetics – –
Endocrinology Hypoglycemia Treatment – –
Endocrinology Lipid disorders Measurements – –
Endocrinology Lipid disorders Primary dyslipidemia – –
Endocrinology Lipid disorders Secondary dyslipidemia – Secondary dyslipidemia
Endocrinology Lipid disorders Physical exam findings – –
Endocrinology Lipid disorders Treatment – NCEP Guidelines of Dyslipidemia
Endocrinology Lipid disorders Drug treatment – Drug Treatment of Dyslipidemia
Rheumatology Arthritis Approach to patients with joint pain – Key Physical Exam Findings in Joint Pain
Rheumatology Arthritis Approach to arthritis Approach to arthritis –
Rheumatology Arthritis Analysis of joint fluid – Analysis of Joint Fluid
Rheumatology Arthritis Comparison of major arthritides – Comparison of Major Arthritides
Rheumatology Arthritis Radiologic features – –
Rheumatology Inflammatory markers & autoantibody testing Inflammatory Markers – –
Rheumatology Inflammatory markers & autoantibody testing Autoantibody Testing – –
Rheumatology Rheumatoid arthritis Definition & epidemiology – –
Rheumatology Rheumatoid arthritis Clinical manifestations – Extra-Articular Manifestations of RA
Rheumatology Rheumatoid arthritis Laboratory & radiologic studies – –
Rheumatology Rheumatoid arthritis ACR/EULAR classification criteria of RA – ACR/EULAR classification criteria of RA
Rheumatology Rheumatoid arthritis Management – RA Therapeutics
Rheumatology Adult onset still’s disease & relapsing polychondritis Adult Onset Still’s Disease – –
Rheumatology Adult onset still’s disease & relapsing polychondritis Relapsing Polychondritis – –
Rheumatology Gout Definition & epidemiology – –
Rheumatology Gout Clinical manifestations – –
Rheumatology Gout Diagnostic studies – –
Rheumatology Gout Acute treatment – Acute Treatment of Gout
Rheumatology Gout Chronic treatment – Urate Lowering Therapy
Rheumatology Calcium pyrophosphate dihydrate deposition disease Definition – –
Rheumatology Calcium pyrophosphate dihydrate deposition disease Etiologies – –
Rheumatology Calcium pyrophosphate dihydrate deposition disease Clinical manifestations – –
Rheumatology Calcium pyrophosphate dihydrate deposition disease Diagnostic studies – –
Rheumatology Calcium pyrophosphate dihydrate deposition disease Treatment – –
Rheumatology Seronegative spondyloarthritis Classification system – –
Rheumatology Seronegative spondyloarthritis Epidemiology & pathogenesis – SpA Epidemiology and Features
Rheumatology Seronegative spondyloarthritis Major clinical manifestations – SpA Distinguishing Features
Rheumatology Seronegative spondyloarthritis Descriptions of skin manifestations – –
Rheumatology Seronegative spondyloarthritis Clinical assessment – –
Rheumatology Seronegative spondyloarthritis Treatment approach – –
Rheumatology Infectious arthritis Etiologies – –
Rheumatology Infectious arthritis Diagnosis – –
Rheumatology Bacterial arthritis Epidemiology & risk factors – –
Rheumatology Bacterial arthritis Clinical manifestations – –
Rheumatology Bacterial arthritis Additional diagnostic studies – –
Rheumatology Bacterial arthritis Treatment – Treatment of Bacterial Arthritis
Rheumatology Bacterial arthritis Prosthetic joint infections – –
Rheumatology Disseminated gonococcal infection Epidemiology – –
Rheumatology Disseminated gonococcal infection Clinical manifestations – –
Rheumatology Disseminated gonococcal infection Additional diagnostic studies – –
Rheumatology Disseminated gonococcal infection Treatment – –
Rheumatology Olecranon and prepatellar bursitis Epidemiology & risk factors – –
Rheumatology Olecranon and prepatellar bursitis Diagnosis – –
Rheumatology Olecranon and prepatellar bursitis Initial therapy – –
Rheumatology Connective tissue diseases Autoantibodies in Patients with Rheumatic Diseases – Autoantibodies in Patients with Rheumatic Diseases
Rheumatology Systemic sclerosis and scleroderma Definition & epidemiology – –
Rheumatology Systemic sclerosis and scleroderma Classification criteria – –
Rheumatology Systemic sclerosis and scleroderma Diagnostic studies & monitoring – Clinical Manifestations of Systemic Sclerosis
Rheumatology Systemic sclerosis and scleroderma Systemic Sclerosis Subgroup Comparison – SSc Subgroup Comparison
Rheumatology Systemic sclerosis and scleroderma Treatment – –
Rheumatology Inflammatory myopathies Definition & epidemiology – –
Rheumatology Inflammatory myopathies Clinical manifestations – –
Rheumatology Inflammatory myopathies Diagnostic studies – Differential Diagnosis of Myositides, Myopathies, and Myalgias
Rheumatology Inflammatory myopathies Treatment – –
Rheumatology Sjogren's syndrome Definition & epidemiology – –
Rheumatology Sjogren's syndrome Clinical manifestations – –
Rheumatology Sjogren's syndrome Diagnostic studies – –
Rheumatology Sjogren's syndrome Treatment – –
Rheumatology Mixed connective tissue disease Definition – –
Rheumatology Mixed connective tissue disease Clinical manifestations – –
Rheumatology Mixed connective tissue disease Diagnostic studies – –
Rheumatology Mixed connective tissue disease Treatment – –
Rheumatology Raynaud's phenomenon Clinical manifestations – –
Rheumatology Raynaud's phenomenon Primary Raynaud's phenomenon – –
Rheumatology Raynaud's phenomenon Secondary Raynaud's phenomenon – –
Rheumatology Raynaud's phenomenon Treatment – –
Rheumatology Systemic lupus erythematosus Epidemiology – Classification Criteria and Clinical Manifestations of SLE
Rheumatology Systemic lupus erythematosus Workup – Autoantibodies in SLE
Rheumatology Systemic lupus erythematosus Treatment – Treatment of SLE
Rheumatology Systemic lupus erythematosus Lupus nephritis – Lupus nephritis
Rheumatology Systemic lupus erythematosus Prognosis – –
Rheumatology Systemic lupus erythematosus Drug-induced lupus – –
Rheumatology Vasculitis Distinguishing Characteristics of Vasculitis Subtypes – Distinguishing Characteristics of Vasculitis Subtypes
Rheumatology Large-vessel vasculitis Takayasu's arteritis – –
Rheumatology Large-vessel vasculitis Giant cell arteritis – –
Rheumatology Medium-vessel vasculitis Polyarteritis nodosa – –
Rheumatology Anca-associated small-vessel vasculitis Differential Diagnosis of ANCA – Differential Diagnosis of ANCA
Rheumatology Anca-associated small-vessel vasculitis Granulomatosis with polyangiitis – –
Rheumatology Anca-associated small-vessel vasculitis Microscopic polyangiitis – –
Rheumatology Anca-associated small-vessel vasculitis Eosinophilic granulomatosis with polyangiitis – –
Rheumatology Anca-associated small-vessel vasculitis Renal-limited vasculitis – –
Rheumatology Immune complex-associated small-vessel vasculitis Henoch-Schonlein purpura – –
Rheumatology Immune complex-associated small-vessel vasculitis Cryoglobulinemic vasculitis – –
Rheumatology Immune complex-associated small-vessel vasculitis Connective tissue disease-associated vasculitis – –
Rheumatology Immune complex-associated small-vessel vasculitis Cutaneous leukocytoclastic angiitis – –
Rheumatology Immune complex-associated small-vessel vasculitis Behcet's syndrome – –
Rheumatology Igg4-related disease Definition & etiology – –
Rheumatology Igg4-related disease Clinical manifestations – –
Rheumatology Igg4-related disease Diagnosis – –
Rheumatology Igg4-related disease Treatment – –
Rheumatology Cryoglobulinemia Definition & types – –
Rheumatology Cryoglobulinemia Etiologies – –
Rheumatology Cryoglobulinemia Pathophysiology – –
Rheumatology Cryoglobulinemia Clinical manifestations – –
Rheumatology Cryoglobulinemia Diagnostic studies – –
Rheumatology Cryoglobulinemia Treatment – –
Rheumatology Amyloidosis Classification – Classification of Amyloidosis
Rheumatology Amyloidosis Clinical manifestations – Clinical Manifestations of Amyloidosis
Rheumatology Amyloidosis Diagnostic studies – –
Rheumatology Amyloidosis Treatment – –
Rheumatology Amyloidosis Prognosis – –
Neurology Change in mental status Definitions – –
Neurology Change in mental status Initial evaluation – Etiologies of Altered Mental Status
Neurology Change in mental status Neuro Exam of Altered Mental Status – Neuro Exam of Altered Mental Status
Neurology Change in mental status Glasgow Coma Scale – Glasgow Coma Scale
Neurology Change in mental status Initial treatment – –
Neurology Change in mental status Diagnostic studies – –
Neurology Change in mental status Further treatment of delirium – –
Neurology Anoxic brain injury Prevalence – –
Neurology Anoxic brain injury Initial evaluation – –
Neurology Anoxic brain injury Induced hypothermia – –
Neurology Anoxic brain injury Ongoing evaluation – –
Neurology Anoxic brain injury Prognosis – –
Neurology Seizures Definitions – –
Neurology Seizures Differential diagnosis – Seizure vs Syncope
Neurology Seizures Etiologies – –
Neurology Seizures Clinical manifestations – –
Neurology Seizures Clinical evaluation – –
Neurology Seizures Diagnostic studies – –
Neurology Seizures Treatment – Antiepileptic Drugs and Side Effects
Neurology Seizures Status epilepticus – Treatment of Status Epilepticus
Neurology Alcohol withdrawal Pathophysiology – –
Neurology Alcohol withdrawal Clinical manifestations – –
Neurology Alcohol withdrawal Clinical Institute Withdrawal Assessment scale for Alcohol – CIWA-Ar Scale
Neurology Alcohol withdrawal Treatment – –
Neurology Ischemic stroke Etiologies – –
Neurology Ischemic stroke Clinical manifestations – Stroke Syndromes by Vascular Territory
Neurology Ischemic stroke Transient ischemic attack – –
Neurology Ischemic stroke Physical exam – –
Neurology Ischemic stroke Acute workup – –
Neurology Ischemic stroke Workup to assess for etiology/modifiable risk factors – –
Neurology Ischemic stroke Acute treatment of ischemic stroke – –
Neurology Ischemic stroke Secondary stroke prevention – –
Neurology Ischemic stroke Patent foramen ovale – –
Neurology Intracranial hemorrhage Classification by location – –
Neurology Intracranial hemorrhage Etiologies – –
Neurology Intracranial hemorrhage Clinical manifestations – –
Neurology Intracranial hemorrhage Workup – –
Neurology Intracranial hemorrhage Management – –
Neurology Weakness & neuromuscular dysfunction Weakness & Neuromuscular Dysfunction – Weakness & Neuromuscular Dysfunction
Neurology Peripheral neuropathies Etiologies – –
Neurology Peripheral neuropathies Clinical manifestations – –
Neurology Peripheral neuropathies Diagnostic studies – –
Neurology Peripheral neuropathies Treatment of neuropathic pain – –
Neurology Guillain-barre syndrome Definition & epidemiology – –
Neurology Guillain-barre syndrome Clinical manifestations – –
Neurology Guillain-barre syndrome Diagnostic studies – –
Neurology Guillain-barre syndrome Treatment – –
Neurology Myasthenia gravis Definition & epidemiology – –
Neurology Myasthenia gravis Clinical manifestations – –
Neurology Myasthenia gravis Diagnostic studies – –
Neurology Myasthenia gravis Treatment – –
Neurology Myopathies Definition & epidemiology – –
Neurology Myopathies Clinical manifestations – –
Neurology Myopathies Diagnostic studies – –
Neurology Headache Primary headache syndromes – –
Neurology Headache Secondary causes of headache – –
Neurology Headache Clinical evaluation – –
Neurology Migraine Epidemiology – –
Neurology Migraine Definition & clinical manifestations – –
Neurology Migraine Treatment – –
Neurology Back and spinal cord disease Differential diagnosis of back pain – –
Neurology Back and spinal cord disease Initial evaluation – –
Neurology Spinal cord compression Clinical manifestations – –
Neurology Spinal cord compression Evaluation & treatment – Conus Medullaris vs Cauda Equina Syndromes
Neurology Nerve root compression Clinical manifestations – Cervical and Lumbar Radiculopathy
Neurology Nerve root compression Neurogenic vs Vascular Claudication – Neurogenic vs Vascular Claudication
Neurology Nerve root compression Treatment of nerve root compression – –
Surgical Issues Abdominal pain Viscera and Area to which pain referred – Viscera and Area to which pain referred
Surgical Issues Abdominal pain Etiologies of Abdominal Pain by Location Etiologies of Abdominal Pain by Location –
Surgical Issues Abdominal pain Inital evaluation – –
Surgical Issues Acute abdomen Definition – –
Surgical Issues Acute abdomen Etiologies – –
Surgical Issues Acute abdomen Inital evaluation – –
Surgical Issues Acute abdomen Initial management – –
Surgical Issues Extremity emergencies Acute limb ischemia – –
Surgical Issues Extremity emergencies Compartment syndrome – –
Surgical Issues Surgical tubes, drains, and wounds Tracheostomy – –
Surgical Issues Surgical tubes, drains, and wounds Chest tubes – –
Surgical Issues Surgical tubes, drains, and wounds Gastrostomy/jejunostomy tubes – –
Surgical Issues Surgical tubes, drains, and wounds Suture/staple removal – –
Ob/Gyn Issues Vaginal bleeding Etiologies – –
Ob/Gyn Issues Vaginal bleeding History & exam – –
Ob/Gyn Issues Vaginal bleeding Laboratory evaluation & imaging – –
Ob/Gyn Issues Vaginal discharge Etiologies – –
Ob/Gyn Issues Vaginal discharge Initial evaluation – –
Ob/Gyn Issues Vaginal discharge Treatment – –
Ob/Gyn Issues Adnexal mass in non-pregnant woman Etiologies – –
Ob/Gyn Issues Adnexal mass in non-pregnant woman Initial evaluation – –
Ophthalmic Issues Acute visual changes Etiologies of Acute Vision Loss – Etiologies of Acute Vision Loss
Ophthalmic Issues Acute visual changes Descriptions & etiologies of other visual changes – –
Ophthalmic Issues Red eye Common Etiologies of Red Eye – Common Etiologies of Red Eye
Ophthalmic Issues Other conditions Optic Nerve Disorders – –
Ophthalmic Issues Other conditions Ocular motor palsies – –
Ophthalmic Issues Initial evaluation Initial evaluation – –
ICU Medications Icu medications ICU Medications – ICU Medications
ACLS Pulmonary edema, hypotension or shock ACLS pulmonary edema, hypotension or shock algorithm ACLS pulmonary edema, hypotension or shock algorithm –
ACLS Tachycardia ACLS tachycardia algorithm ACLS tachycardia algorithm –
ACLS Bradycardia ACLS bradycardia algorithm ACLS bradycardia algorithm –
ACLS Vf/pulseless vt, asystole, & pea ACLS VF/Pulseless VT, asystole, & PEA algorithm ACLS VF/Pulseless VT, asystole, & PEA algorithm –
Quick References Chest imaging patterns Chest Imaging Patterns – Chest Imaging Patterns
Quick References Peripheral smear findings Peripheral Smear Findings – Peripheral Smear Findings
Quick References Heparin for thromboembolism Heparin for Thromboembolism – Heparin for Thromboembolism
Quick References Heparin for acs Heparin for ACS – Heparin for ACS
Quick References Warfarin loading nomogram Warfarin Loading Nomogram – Warfarin Loading Nomogram
Quick References Warfarin-heparin overlap therapy Warfarin-Heparin Overlap Therapy – Common Warfarin-Drug Interactions
Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox_coretopics&oldid=1268914"